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Abstract 
The repair of large segmental bone defects is problematic with a high risk of infection, 
large amounts of soft tissue damage, and fracture stabilization difficulties.  This preliminary study 
evaluates three large animal caprine models.  These models will be used in future studies to 
examine the effects of negative pressure to induce bone and soft tissue growth into porous metal 
implants for the repair of large segmental defects.   
In Aim #1 bilateral surgery was performed on 6 goats, attaching one large porous 
titanium implant to the lateral side of each femur.  One leg of each animal served as the control 
while the other side was treated with Negative Pressure Wound Therapy (NPWT) at either -125 
mmHg or -200 mmHg.  Tissue ingrowth for each negative pressure was examined at 6, 9, and 12 
days.  After gross examination, 6 of 6 animals showed improved tissue adhesion to the implant 
treated with NPWT when compared to the implant not treated with NPWT.   
Two pilot animals were added to the original protocol in order to explore the iliac crest as 
a better implant location for soft tissue study.  The iliac crest was easier to access, maintain 
cleanliness of the surgical site, and maintain fixation over the greater trochanter and is 
recommended as the preferred location for future soft tissue studies.     
In Aim #2 unilateral surgeries were performed on 8 goats, replacing a 35 mm diaphyseal 
segment on the tibia with a porous titanium cylinder (20 mm diameter) and using orthogonal 
plates to provide rigid fixation.  Four goats received no additional therapy and served as the 
controls while the other 4 goats received NPWT at -125 mmHg directly on the implant for 24-72 
hours.  Two goats from each group were sacrificed at 6 weeks and 12 weeks and examined 
qualitatively and biomechanically.  Longer durations of therapy need to be examined to determine 
the effects of negative pressure therapy on bone growth. 
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Chapter 1 Introduction and Review of Literature 
1.1 Introduction 
 This pilot study is the initial investigation into the creation of a device that that will apply 
NPWT across a porous metal implant to enhance the propagation and growth of bone and soft 
tissue for the treatment of segmental bone defect injuries.  This study examines three in vivo 
models to be used in future studies that will evaluate the effectiveness of negative pressure to 
induce bone and soft tissue growth into porous metal implants.  The development of such a 
device could greatly reduce the reconstruction time of a salvaged limb, improving patient care for 
those suffering from traumatic extremity injuries.  In addition to improving patient care, the 
outlined research expands the knowledge within the fields of treating large segmental skeletal 
defects ranging from Extremity War Injuries (EWIs) to osteosarcoma osteotomies, as well as 
Negative Pressure Wound Therapy (NPWT) and porous metal implants.  
 The combination of NPWT, with its ability to induce angiogenesis, and newly developed 
porous metal implants, with similar mechanical properties to bone, may have potential use in the 
treatment of severe, traumatic segmental defects at an earlier stage in the reconstruction process.  
The ability of a device to be rigidly implanted at the first definitive debridement and to provide 
internal fixation in an open and contaminated wound would speed recovery and reduce the 
number of procedures needed, thereby reducing cost of recovery.   
 Before the benefits of such a device can be determined, in vivo models that can be used to 
study soft tissue and bone healing in segmental defect injuries need to be established.  Until 
recently, the use of NPWT has been mostly limited to surface applications.  This study will also 
provide valuable information about NPWT and its potential use in closed wounds as well as 
information about bone and soft tissue growth into porous titanium implants.   
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 The following sections of this chapter provide more in depth, background information 
about the related topics in order to understand the problem and proposed solution examined in 
this study. 
1.2 Problem: Segmental Trauma Injuries  
 Peri-articular, open segmental trauma injuries are a prevalent injury and present several 
challenges for repair.  They are often the result of a high impact, traumatic event such as a blast, 
collision, or fall and are irregular in nature.  Infection in such wounds is of major concern due to 
the open access of dirt and other foreign matter beneath the skin, into the underlying tissues.  In 
addition, because of their location 
away from the central organs, and 
priority of healing given to other 
parts of the body, blood flow is often 
impaired resulting in decreased 
healing in extremities leading to 
nonunion, malunion, and/or 
compartment syndrome.   Tibial 
shaft fractures are one example of 
such an injury and alone have an 
incidence of 17-21 per 100,000 in 
the population and represent 2% of all fractures in adults [1].  From 1994 to 2003, 10,082 open 
femoral fractures and 22,479 open tibial or fibular fractures were registered in the American 
College of Surgeon’s National Trauma Data Bank [2].        
Extremity War Injuries (EWI) with large, open segmental defects are another type of 
open segmental trauma injury, often the result of a munitions round or improvised explosive 
device (IED) and are a prevalent, high morbidity challenge for the military trauma management 
Figure 1. Extremity war injury with large open periarticular 
defects 
Used with permission, open-access article. 
O'Brien PJ, Cox MW. Stents in tents: endovascular therapy on 
the battlefields of the global war on terror. J Surg Radiol. 2011 
Jan 1;2(1). 
4 
 
system, presenting all of the challenges previously mentioned. Between October 2001 and 
January 2005, 1,281 US casualties were reported in operation Iraqi Freedom and Enduring 
Freedom, of which 75% were caused by explosive munitions [3].  By August 2007, the U.S. had 
suffered 27,400 U.S. casualties, 24% of which had a fracture and of which 82% were open 
fractures [4].   In addition to the previously mentioned issues of infection and healing, large 
amounts of burned or pulverized tissue from a blast makes skin closure and limb repair difficult 
[4]. 
Without the same hazard for infection, bone cancers, such as osteosarcoma and Ewing’s 
sarcoma, can be equally traumatic to a patient, leaving a large skeletal and soft tissue defect after 
surgical removal of the cancer.  Although infection due to the presence of foreign matter is not as 
much of a concern in surgically created segmental defects, repair and healing can be difficult 
because of a compromised immune system and patient fatigue from additional cancer therapies.      
 Currently, best practice to reconstruct a limb damaged due to trauma is through multiple 
procedures that extend over a long period of time.  The first step is initial stabilization and 
debridement of the wound site.  Next, external fixation and eradication of infection takes place.  
Finally, reconstruction and wound coverage takes place often involving multiple procedures.  The 
recovery process for such traumatic extremity injuries can involve months and even years of 
repeated operations by multiple surgeons at multiple hospitals, often times causing more 
psychological trauma to the patient than the event that caused the injury [3, 4]. 
 Current practice of immobilizing the fracture by external fixation is not ideal as external 
fixation is less effective in very proximal appendicular skeletal injuries [4] and can also be 
cumbersome and uncomfortable for the patient, especially if multiple injuries are sustained, as is 
often the case [3].  In addition to discomfort, external fixation devices make vascular and nerve 
repair as well as Vacuum Assisted Closure (V.A.C.) and skin coverage inconvenient.  
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 A better alternative to external fixation is an internal fixation device used in combination 
with Negative Pressure Wound Therapy (NPWT) that can be used earlier in the reconstructive 
process.  A delay in treatment could be a contributing factor for infection risk.  In a retrospective 
study of 36 open tibia fractures, Cierny et al. found a faster rate of healing (4.0 months vs. 6.4 
months) and lower frequency of wound healing disturbances (20.8% vs. 83.3%) in tibia fractures 
that received wound coverage within 7 days of the incident causing the injury [5].  In a similar 
study examining 38 patients with Gustilo grade IIIB open fractures, patients who underwent 
definitive coverage with vacuum assisted closure < 7 days post injury were significantly less 
likely to have infection (12.5%) compared to 57% incidence of infection for patients having 
coverage > 7 days post injury [6].  Fick et al. concluded that conversion to a definitive fixation 
technique should not be delayed after seeing that infection rates increased with intramedullary 
nailing proportionally with the time external fixation had been left in place [4].  This evidence 
supports that earlier definitive fixation and wound coverage is preferred to the current methods of 
temporary external fixation followed by permanent fixation.  
 Treating large, open, segmental defects such as EWIs, and other high impact traumatic 
injuries is a problem for which there are currently no easy solutions to repair large segmental 
bone defects without multiple surgeries over a long period of time.  Advancements in treatment 
methods and devices to safely, quickly, and effectively treat such injuries are sorely needed. 
1.3 Negative Pressure Wound Therapy (NPWT) 
 Since the early 1990s, it has been known, but not fully understood, that NPWT provides 
advantages in closing wounds and inducing growth of granulation tissue [4, 6-12].  NPWT is 
most commonly used in surface applications such as diabetic ulcers or amputations where the 
patient has negative factors that may compromise normal healing.  Factors that increase a 
patient’s risk for poor healing include: advanced age, Diabetes Mellitus, nutritional status, 
corticosteroid medication, peripheral vascular disease, or tobacco use [8]. 
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NPWT provides several advantages through which it improves healing of health 
compromised patients.  The mechanisms of action that are believed to improve the healing of 
surface tissue are shown in Figure 2 and include the stabilization of the surrounding tissue, 
removal of excess fluid, and mechanical stimulation.  The removal of excess fluid from the 
wound is believed to help by removing 
contamination and waste products from 
the wound site.  NPWT may create and 
enhance perfusion conditions 
surrounding the wound.  For example, 
one study showed improved cell growth 
into porous metals under perfusion 
conditions [13].  The precise mechanisms 
of healing caused by mechanical stimulation are unknown; however, mechanical 
microstimulation and stabilization of the surrounding soft tissue has been shown to be present, as 
indicated from 3-D computational models [14].  The optimal negative pressure to provide 
sufficient stabilization of the surrounding tissue, removal of excess fluid, and microstimulation in 
a surface application has been determined to be -125 mmHg [11].  We chose to take a preliminary 
look at alternative negative pressures because tissue in a closed wound application may behave 
differently to negative pressure therapy than the surface wounds it is most commonly used for.     
V.A.C.
®
 (Vacuum Assisted Closure) dressings are commonly used in the reconstruction 
treatment of severe EWIs [3] and facilitate the same advantages when it comes to wound healing 
as with amputations or diabetic ulcers.  The use of NPWT for the treatment of EWIs is mostly 
limited to injuries requiring skin grafts, and then, only in an open wound, surface application.  
One reason NPWT has been limited to surface applications has been the question of how deep 
into tissue the effects (i.e. strain) of negative pressure are effective.  One study suggests that 
Figure 2. Negative pressure wound therapy diagram of 
mechanisms of action. 
tissue 
stabilization
mirostimulation
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depth of pressure for NPWT is less than 1 mm from the tissue/wound interface [15].  With the 
depth of therapy relatively shallow, this begs the question of whether there would be enough area 
affected in a closed wound to make NPWT useful.  We will discuss more about the use of a 
porous metal implant to apply negative pressure in a closed wound in the next section.   
While the clinical benefits of NPWT used in surface applications have been well 
documented, little is known about its effectiveness when used beneath the surface layers of the 
skin, especially in a closed wound.  Recently in 2011, an  in vitro bench top model along with 
computer models were used to examine how NPWT relieves stress and strain on the suture line 
[16].  However, this study did not examine any effects below the layer of the skin.  A similar 
study showed that NPWT improves healing of the dermal layers after 3 days using a porcine 
model but again this did not show the effects of NPWT on the deep tissue layers of a closed 
wound [10].  Little has been done to explore the use of negative pressure to treat closed wounds.  
The lack of knowledge for such an application makes in vivo validation of the therapy vital to 
ensure that the device delivers the expected therapy to the desired location.  Even less has been 
done to examine the effects of NPWT beneath the skin surface making this research vital to our 
understanding of the effects of NPWT on sub-dermal wound healing.   
 One possible threat to wound healing caused by NPWT is bacterial bioburden, which can 
be harbored in a negative pressure dressing.  Demaria et al. examined the effects of NPWT in the 
treatment of acute open wounds in 10 dogs.  Full-thickness 4 cm by 2 cm wounds were created on 
the ante-brachium with one side receiving NPWT and the other side receiving standard wound 
dressings.  The wounds were observed and evaluated at 8 time points over a 21 day period.  
Granulation tissue appeared earlier, was smoother, and was less exuberant in the wounds treated 
with NPWT. However, prolonged use of NPWT prevented wound contraction and 
epithelialization giving reason to suggest little benefit in continuing NPWT past 10 days [9]. One 
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explanation may be that after 10 days, the dressing may have caused an environment antagonistic 
to healing.  
In contrast, a certain increased level of expected bacterial bioburden was shown by 
Demaria to have non-adverse effects on wound healing.  In the previously mentioned study 
aerobic tissue cultures were taken at 7 and 14 days and, although no animals showed clinical 
signs of infection over the course of the study, after 7 days bacterial load was higher in wounds 
treated with NPWT [9].  The normal presence of bacterial bioburden in V.A.C. dressings has also 
been previously demonstrated in other studies [17].  
A similar antagonist to wound healing is the presence of an unregulated air leak in the 
sealing drape, which resulted in progression of the secondary wound due to dehydration and 
progressive necrosis [11].  When applied in the wrong manner or for too long, such as in the case 
with an air leak or without proper perfusion, NPWT can cause an antagonistic environment for 
tissue growth and wound healing; however, a normal level of bacterial bioburden may be 
expected in a properly applied NPWT dressing.   Overall, when applied appropriately, NPWT has 
proven to be an effective treatment for healing surface wounds.   
1.4 Porous Metals 
 Relatively new porous metals have demonstrated improved characteristics over solid 
metal implants, including mechanical strength and biocompatibility, making them well suited for 
orthopedic applications. A recent study reviewed fabrication methods of porous metals for use in 
orthopedic applications [18].  Porous metals, such as titanium BIOFOAM™ (Wright Medical 
Technologies; Arlington, TN), have a decreased rigidity and elastic modulus when compared to 
the same implant made of solid metal and gives porous metals a more similar rigidity and elastic 
modulus to that of bone.  This similarity in mechanical strength between bone and porous metals 
could improve fixation issues, such as stress shielding, which is caused by a sudden change in the 
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rigidity between an implant and the local tissue, making them ideal for providing the structural 
support required of an internal fixation device used in load bearing applications [19].   
 However, one concern with using an entirely porous metal implant in a load bearing 
application is poor fatigue strength as it has been shown that the high cycle fatigue strength of 
porous coated Ti-6Al-4V alloy is approximately one-third that of the solid alloy of equivalent 
shape and is probably less than that for entirely porous implants [20].    One way to improve upon 
the fatigue strength of porous metal might be a post sintering heat treatment which showed a 15% 
improvement in fatigue properties of porous Ti-6Al-4V coatings [21].   One limitation of this 
study for the application of an entirely porous metal implant is that it tested a porous Ti coating 
and not entirely porous implants.  If the mode of failure was at the solid/porous interface, an 
improvement upon this union may not improve the fatigue strength of an entirely porous metal 
implant without changing its properties.  
While the fatigue strength of porous titanium implant itself does not change with bone 
ingrowth, the fatigue life of the implant and bone construct may be impacted for the better.  If 
bone ingrowth provides union at the bone/metal interface, the bone can share a fraction of the 
loading, lengthening the fatigue life of the overall construct. 
 The incorporation of bone and soft tissue into a porous metal implant is ideal both to 
improve mechanical strength (bone) and to prevent the colonization of biofilms on the surfaces of 
the implant (soft tissue).  The advanced biocompatibility of titanium and other such 
biocompatible metals allows for proliferation of tissues through the implant. Complete ingrowth 
of fibrous tissue including vessel formation has been demonstrated in porous tantalum implanted 
in the backs of dogs [22].  Similarly, 65-70% Ti foam seeded with SAOS (bone tumor cells) and 
primary osteoblasts demonstrated complete ingrowth of cells through implants in perfusion 
conditions in vitro [13].  If these results can be duplicated in vivo, tissue growth throughout the 
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entire implant is beneficial in order to prevent the invasion of biofilms and/or bacteria in the 
porous network.  This ingrowth also demonstrates potential for bone formation inside of the 
implant.     
A porous metal implant may provide a solution for how to distribute negative pressure 
therapy to a sub dermal wound.  NPWT is commonly used to treat open fractures and encourage 
soft tissue healing where the loss of skin is prevalent.  In a surface wound, a large surface area is 
available for therapy application whereas the area available in a closed injury compartment is 
limited.  A porous metal implant, such as that made of titanium or tantalum, has a similar 
geometric structure to that of a traditional sponge.  Such a material provides an open porous 
network with many times the surface area of a solid implant of the same geometry, and allows 
negative pressure therapy to be distributed through the implant to the surrounding tissue.  With 
this ability to distribute negative pressure while holding a rigid shape, porous metals may provide 
the solution for how to distribute NPWT in a closed wound to repair segmental defects faster.   
As mentioned in section 1.2, there is evidence that earlier coverage of open fractures can 
decrease risk of infection and speed healing time [4-6].  If an internal fixation device can be 
combined with NPWT in a closed wound application, such a device could be used earlier in the 
reconstruction process and improve healing.    
 In designing a porous metal implant, pore size must be considered so as to provide 
sufficient mechanical strength and also be optimal for tissue ingrowth.  It has been recognized 
that while pore shape has not been reported to impact biologic response, interconnecting pore size 
is acknowledged as a critical factor in successful bone ingrowth [18].  An optimum pore size 
required for implant fixation is currently undefined, but the consensus to optimize mineralized 
bone ingrowth is that pores between 100 µm and 400 µm are required [23].  However, Bobyn et 
al. demonstrated successful bone ingrowth into porous coatings with pores down to 50 µm and 
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Itala et al. also showed the formation of an osteonal bone structure in pores sizes down to 50 µm 
[24, 25]. Pore size can directly affect tissue ingrowth and must be considered when designing an 
internal fixation device made of porous metal. 
 Several investigators have coined terms to describe the biological events in porous 
implant healing and stabilization which are useful in the evaluation and understanding of 
biological responses to porous metal implants [18].  The term osteoconduction refers to the 
situation where bone grows across the surface of an implant [26].  The term osseointegration is 
the rigid fixation of an implant by the formation of bony tissue around the implant without the 
growth of fibrous tissue at the bone implant interface [26].  Osseointegration is dependent on 
osteoconduction and maintains fixation of the implant over extended periods while 
osteoconduction may be short lived.  The term bone ingrowth refers specifically to bone 
formation within a porous surface structure [27] and can also be used for growth of bone into an 
entirely porous implant.  Bone ingrowth is dependent on osteoconductive surfaces and will lead 
to successful osseointegration of the implant.    
1.4.1  BIOFOAM™ 
For this study, Wright Medical Technologies, Inc. (Arlington, TN) manufactured the 
implants out of their BIOFOAM™ material.  BIOFOAM™ is marketed as a cancellous titanium 
matrix and has similar mechanical properties to that of bone.  It was introduced to the market in 
2008 as a coating on implants for total knee replacement.  Wright’s only entirely BIOFOAM™ 
implant is a wedge system marketed as rigid fixation devices for use in foot and ankle 
osteotomies.  
Wright claims several characteristic material advantages of BIOFOAM™ over other 
porous metals such as sintered titanium beads and Trabecular Metal™ (Zimmer, Inc.; Warsaw, 
IN). One such claim is that BIOFOAM™, similar to Trabecular Metal™, achieves 200%-260% 
greater bone ingrowth than sintered beads at 12 weeks. BIOFOAM™ has a porosity of 60-70% 
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BIOFOAM
™
 – Wright 
Medical
TRABECULAR 
METAL
™
 - Zimmer 
(Implex)
REGENEREX
™
 - 
BIOMET
®
GRIPTON - DePuy R2 Acetabular Shells 
with STIKITTE
™
 – 
Smith and Nephew
Porosity 60-70% 70-80% 67% 63% 60%
Pore Diameter 500 µm 200-600 µm 100-600 µm 300 µm 200 µm
Pore 
Interconnectivity
interconnected pores interconnected pores interconnected pores
Limited Interconnecting 
Porosity
interconnected pores
with a pore diameter of approximately 500 microns [24, 28, 29]. The porosities of BIOFOAM™ 
and its competitors can be seen in Table 1.  The compressive strength of BIOFOAM™ is 86 
MPa, which is between cortical bone (140 MPa) and trabecular bone (10-13 MPa) and slightly 
greater than Trabecular Metal™ (76 MPa) (Table 2).  The compressive modulus of BIOFOAM™ 
is 2.7 GPa, slightly higher than trabecular bone (2 GPa) and much less than cortical bone (15 
GPa) (See Table 2).  As previously mentioned, having a strength and modulus more similar to 
that of actual bone is advantageous and prevents stress shielding.  BIOFOAM™ also has a 
coefficient of friction of .55, slightly higher than Trabecular Metal™ (.44), plasma spray (.4), and 
sintered beads (.32), and allows for more stable fixation than a smooth implant surface (See Table 
3).  A high coefficient of friction is especially advantageous when trying to achieve natural 
fixation, without the use of bone cement, where high shear stress can occur, such as the outer 
surface of an acetabular cup used in a total hip replacement. All material properties for 
BIOFOAM™ were cited in Wright brochures and the original internal reports could not be 
obtained from Wright [28, 29].  
 
 
 
 
Cortical bone BIOFOAM
™
 – 
Wright Medical
Trabecular Metal Trabecular bone
Compressive Strength 140 MPa 86 MPa 76 MPa 10-13 MPa
Compressive Modulus 14 GPa 2.7 GPa 3.0 GPa 2.0 GPa
Table 2. Compressive strength and compressive modulus of BIOFOAM™, trabecular metal, and bone. 
Table 1. Pore characteristics of porous metals. 
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1.5  Large Animal Model 
 A study measuring the peak cutaneous blood flow at varied levels of negative pressure 
was done on the uninjured arms of volunteer subjects [30].  However, this provided little insight 
into the actual effects on wound healing as the therapy was applied to a closed skin surface 
without injury.  A live animal model provides the best method of examining the effects of a 
therapy or method on wound healing. To examine bone and soft tissue ingrowth, an in vivo model 
is required.  Birds [31], dogs [9], pigs [11], sheep [32], and goats [33] have all been used in vivo. 
 While pigs are known to have similar vasculature and tissue properties to humans, their 
limbs are relatively short when compared to human limbs and are not long enough for a 
segmental defect model.  In contrast, birds have dissimilar soft tissue to that of mammals and are 
not good for soft tissue models of wound healing.  Birds also have a small skeletal structure 
relative to humans. 
 Goats were chosen for this study because they provide a similar skeletal structure size to 
that of humans for a large implant and also provide an adequate soft tissue model for examining 
wound healing.  Other groups have successfully used goats to examine the healing of large 
segmental defects and have established fluorochrome labeling techniques to analyze bone growth 
[33-35]. 
1.6 Wound Healing 
 Soft tissue wound healing has been widely investigated and involves a multistep process 
to go from wound formation to advancd healing.  Initial stages include blood clot formation and 
inflammation.  Inflammatory responses are followed by proliferation and migration of dermal and 
Table 3. Coefficient of friction or porous metals. 
BIOFOAM™ – 
Wright Medical
Trabecular 
Metal™ - Zimmer
Plasma Spray Sintered Beads
0.55 0.44 0.40 0.32
Cofficient of Friction
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epidermal cells along with matrix synthesis to fill the wound gap and reestablish a skin barrier.  
Lastly, full recovery of skin tissue and restoration of skin aesthetics is achieved through tissue 
remodelling and differentiation [36].  
 The growth of granulation tissue reestablishes a skin barrier and involves the proliferation 
and migration of dermal and epidermal cells.  In large segmental defects where deep tissue 
damage has occurred, a race between granulation tissue formation and the formation of a bacterial 
biofilm takes place deep inside of the wound.  The rapid growth of healthy tissue is extremely 
important when implants are used to provide fixation, especially porous metal implants, because 
their surfaces provide an ideal surface for biofilm formation.  Once biofilm has colonized and 
taken over an implant, the only option of treatment is to remove the infected implant.  NPWT 
provides the advantage of sealing out biofilm causing bacteria and could also allow for the 
infusion of antibiotics to further prevent and fight early stage infection in deep tissue wounds.      
 When skeletal injuries also occur along with a wound that results in a missing section of 
bone, this is called a segmental defect.  A critical segmental defect is a defect in the bone that will 
not heal naturally.  The presence or absence of periosteum surrounding the bone may be more 
important to the determination of a critical size segmental bone defect than the actual size of the 
defect.  In a study attempting to reconstruct large diaphyseal segmental bone defects in goat 
femurs, it was concluded that the presence of periosteum is essential for the healing of segmental 
defects [33].  Without the presence of periosteum to allow for revascularization to supply new 
bone formation, new bone growth cannot take place.   
Shallow bone growth into porous titanium implants has been well documented. Porous 
metals are commonly used as surface coatings on acetabular cups and fermoral implants to 
achieve biological fixation in hip arthroplasties [18].  However, the maximum ability for bone 
ingrowth into porous metals remains unknown.  While several studies have looked at bone 
ingrowth, the animal models used have been small and even in the largest animal model, dogs, 
the implants were relatively small compared to bone size [33].  In that study, limited bone 
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ingrowth was achieved at 26 weeks if the periosteum was left intact.  The maximum depth of 
bone ingrowth into a porous metal using a large implant begs to be investigated.      
 Along with missing periosteum, other factors that increase a patient’s risk for poor bone 
healing are the same risk factors that affect soft tissue healing; advanced age, Diabetes Mellitus, 
nutritional status, corticosteroid medication, peripheral vascular disease, or tobacco use [8].   
1.7 Fluorescent Staining of Bone 
 Fluorochromes are calcium seeking substances that are incorporated into the 
mineralization front of bone.  The florescence of such substances is observed histologically 
through excitation with ultraviolet (UV) or blue light.  There are several groups of fluorochrome 
labels that include tetracyclines (oxytetracylcine), fluoresceins (calcein), alizarins, and other 
fluorochromes including xylenol orange.  Calcein is generally the preferred fluorochrome label 
because of its intense visualizations with lower dosing levels.  However, multiple labels can be 
used to observe bone materialization dynamics.  The different fluorochromes that are 
incorporated at the different times of their administration can be used to accurately see the bone 
growth over time.  For instance, Bullens et al. used a calcein green label (20 mg/kg) administered 
13 weeks postoperatively and alizarin (30 mg/kg) administered 2 days before euthanization at 26 
weeks [33].  Other groups have also shown effective use of multiple label regimens to observe 
bone growth [33, 37, 38].  Specific Aim #2 utilizes a multiple fluorochrome label regimen to 
observe bone growth in a segmental tibia defect in goats (Section 3.2.2). 
1.8 Histological Processing 
 Histological processing of porous titanium implants presents several complications over 
standard histological processing of soft tissues because of their size, porosity and hardness. The 
implants themselves are larger than small tissue biopsies and because of their porosity, unlike 
solid implants where the embedding medium need only completely surround the implant, the 
embedding medium must fully penetrate through an entirely porous implant.   If the embedding 
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medium does not penetrate through the entire specimen, the tissue in the pores will smear during 
the cutting process.  There must not be a sudden transition in structural rigidity between titanium 
and the embedding medium during the cutting process otherwise the shear forces created by the 
cutting medium (blade or wire) will cause the different materials to separate.  Standard 
microtome techniques cannot be used to slice through a titanium implant.  Instead, a diamond 
wire saw or Buehler Isomet saw must be used to section a titanium specimen.    
 To address these complications, histological processes had to be developed in order to 
analyze the unique implants.  To match hardness of the implant, it was suggested that Spurr low 
viscosity embedding medium be used as the embedding medium [37].  Also recommended was 
the use of a diamond wire saw that slowly cuts through the specimens, producing little to no heat 
so as not to damage the specimen.   
 Several fixatives can be used to preserve the protein structure of tissues for histology 
including ethanol, formalin, and paraformaldehyde. Ethanol is a common fixative and can also be 
used for dehydration; however, because it acts through coagulation, it has poor penetration ability 
and was not a viable option for our larger specimens. Instead, ten percent neutral buffered 
formalin was recommended as the preferred fixative for this study because of its ability to 
penetrate into thicker tissue samples [22].  Acetone was also recommended in place of ethanol to 
dehydrate the specimens because of their large size [37].   
Large, porous titanium specimens presented several challenges when it came to 
histology.  Custom protocols had to be developed to examine the bone and soft tissue ingrowth 
into the large, porous titanium implants.     
1.9 Biomechanical Evaluation 
Stable fixation is essential to bone healing.  A simple gait score has previously been used 
to evaluate the recovery of animals recovering from a segmental injury and is a good indicator to 
the stability of the fixation.  Unstable implants will not allow the bone to heal and will cause pain 
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to the animal, not allowing the animal’s gait to return to normal.  The following gait score system 
has been used in various studies to evaluate the recovery of animals following surgery [33].  
Gait observation scale:  
  0 = not used at all 
  1 = supported incidentally 
  2 = loaded in a standing position and incidentally while walking 
  3 = loaded in a standing position and while walking but with a limp 
  4 = normal walking and standing pattern 
 Natural fixation occurs when bone has grown into the pores of an implant.  
Biomechanical evaluation is an effective method to evaluate the stability of fixation between both 
bone and soft tissue to porous metal implants and is somewhat representative of the amount of 
bone ingrowth.  A torsion test has been demonstrated as an effective means of evaluation of bone 
fixation and a pullout test has been demonstrated as an effective means of evaluation of soft tissue 
fixation [22, 33].   
1.10 Suggested Therapy Solution 
 At an AAOS Extremity War Injuries III meeting of military injury specialists in 2008, it 
was agreed that the development of a resorbable bone substitute impregnated with antibiotics 
and/or growth factors and compatible with internal fixation techniques is desired for the repair of 
large open segmental defects.  Such a device would be withheld until the wound had been 
eradicated of all infection and it had been determined that the limb would be likely to survive.  
Used in such a manner, the bone substitute device could reduce the number of procedures needed 
after its implantation.  Current resorbable materials used for an internal fixation device have 
several disadvantages. Calcium based bone substitutes have the same hazard of fostering 
osteomyelitis as does bone [34] and non-calcium based scaffolds provide inadequate structural 
support.  Also, depending on if any drugs or growth factors are used, such an implant could have 
high costs.  To overcome these obstacles, this research seeks to combine Negative Pressure 
Wound Therapy (NPWT) with a porous metal implant, to develop an internal fixation device to 
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be used in EWI reconstruction. NPWT is known to promote granulation tissue growth and porous 
meals have similar mechanical properties to bone. 
 With a porous structure similar to that of a traditional sponge, negative pressure can be 
distributed throughout the porous network of a porous metal implant using a similar method to 
traditional NPWT techniques.  If negative pressure has a similar effect in a sub-dermal 
application on bone and soft tissue growth as it does in a traditional surface application, NPWT 
may be able to be used to repair segmental bone defects more rapidly. 
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Chapter 2  Specific Aims 
 The objective of this research is to establish in vivo models that can be used to examine 
the effectiveness of negative pressure to induce bone and soft tissue growth into a porous metal 
implant for the application of segmental bone defect reconstruction.  Negative Pressure Wound 
Therapy (NPWT) is known to promote granulation tissue growth [7, 9, 10, 12, 36] and porous 
metal implants have similar mechanical properties to that of bone [24, 32, 39].  This preliminary 
study will move us closer to the 
development of an internal 
fixation device and/or treatment 
to be used in the reconstruction 
of segmental defect injuries and 
establish in vivo models for the 
evaluation of such a device. 
This research accomplishes this objective through completion of two specific aims. In Specific 
Aim #1 the granulation tissue block was used to assess effectiveness of NPWT to induce soft 
tissue growth into the implant at two different implant locations (greater trochanter and iliac 
crest) using an in vivo caprine model. In Specific Aim #2 the tibia segment implant was used to 
assess effectiveness of NPWT to induce bone growth into the implant using a tibial segmental 
defect in an in vivo caprine model.  These in vivo models were developed to investigate the 
hypothesis that NPWT would increase both the amount and speed of bone and soft tissue 
ingrowth into porous titanium implants.     
2.1  Specific Aim #1 – Soft Tissue Growth Models 
2.1.1 Specific Aim #1a – Greater Trochanter 
 Specific Aim #1 evaluated the use of a goat model to determine the effectiveness of 
negative pressure in promoting soft tissue ingrowth into large porous metal implants. The early 
Figure 3. Research flow chart 
Specific Aim 1: Device Design 
and Evaluation (in vitro)
Specific Aim 2: Device Evaluation 
(in vivo)
Porous Titanium 
Implants
Negative Pressure 
Wound Therapy
Medical Technologies:
Design feedback
Problem: Difficulty Treating Large 
Skeletal Segmental Defects
Objective: Device for early treatment 
of Extremity War Injuries
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formation of soft tissue throughout the implant is 
an expected precursor to bone formation and 
beneficial for preventing the colonization of 
bacteria and the formation of biofilms on the 
surfaces of the implant.  This is advantageous in 
trying to heal a contaminated wound such as an 
EWI.  To maximize our potential to see a 
difference in tissue ingrowth, we examined this 
effect at two different negative pressure levels      
(-125 mmHg and -200 mmHg) and at three 
different postoperative time points (6, 9, and 12 days).  The implant was attached to the greater 
trochanter.  A diagram of how the therapy was applied in Specific Aim #1 can be seen in Figure 
4.  Two different levels of negative pressure were examined because of the variance between the 
sub-dermal application examined in this study and the traditional surface wound application.    
2.1.2 Specific Aim #1b – Iliac Crest 
Several complications with using the greater trochanter in Specific Aim #1a led to the 
addition of two pilot animals to test the use of iliac crest as a better site for implantation for 
examination of soft tissue in a non-load bearing application for future studies.  This was not a part 
of the original study; however, the iliac crest offered potential advantages over the greater 
trochanter including easier access to the incision site, less threat of loss of implant fixation, and 
improved cleanliness of the surgical site.   
2.2 Specific Aim #2 – Bone Growth Model 
 Specific Aim #2 evaluated the effect of negative pressure in promoting bone ingrowth 
into large porous metal implants. Current bone ingrowth is limited to only several mm [23].  
Mechanical strength of the construct was examined at two time points (6 and 12 weeks) and bone 
Figure 4. Application of NPWT in Specific 
Aim #1 with arrows indicating pressure and 
fluid flow. 
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ingrowth was assessed histologically and 
mechanically.  It was hypothesized that deeper 
and faster bone regeneration would occur in 
implants treated with negative pressure.  A 
diagram of how the therapy was applied in 
Specific Aim #2 can be seen in Figure 5.  
soft tissue
bone
skin
T.R.A.C. pad to NPWT
porous metal 
implant
marrow
Figure 5. Application of NPWT in Specific Aim 
#2 with arrows indicating fluid and pressure flow. 
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Chapter 3 Specific Aim #1a (Soft Tissue Models) – Greater Trochanter 
 An in vivo caprine model was used to assess tissue ingrowth.  Goats were chosen because 
of their similar bone size to that of human as well as successful development of the model by 
other research groups (AFIRM).  Six Spanish/Boer cross goats, ages 4-6 and weighing 40-60 kg, 
were used for Specific Aim #1a.  Breakdown of the research groups for each Specific Aim can be 
seen in Table 4.  A soft tissue ingrowth implant to be made of porous titanium implants was 
designed to deliver NPWT through the implant to the surrounding soft tissue.  Design of this 
implant is described in following section.  The Animal Care and Usage Protocol (ACUP), 
describing the use of animals in this 
study, was approved by the 
Institution For Animal Care and 
Usage Committee (IACUC). The 
medications used for this study along with their purposes and dosing information can be found in 
Appendix A. 
3.1  Implant Design (Aim #1) - Tissue Ingrowth Implant   
 The tissue ingrowth implant was designed to 
evaluate the effects of NPWT in promoting 
granulation tissue growth into large porous titanium 
implants.  Wright Medical, Inc. agreed to supply 
the tissue ingrowth implant, at machining cost, 
made out of their porous titanium BIOFOAM™ 
material. The original task described a 35 by 20 by 
15 mm implant to be used.  A 3-D model of the 
tissue ingrowth implant can be seen in Figure 6.  The ends were rounded and a beveled edge was 
added to the top of the implant to reduce irritation of the surrounding tissue, which might cause 
Figure 6. Soft tissue ingrowth implant 
Table 4. Specific Aim #1 animal groups 
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an adverse reaction, and affect natural wound healing.  Two 2.7 mm diameter counter sunk holes 
were machined for the two screws used to anchor the implant to the bone.  The smallest diameter 
holes of sufficient length to provide proper fixation to the bone were chosen in order to reduce the 
amount of interference of the screws with tissue growth inside of the implant.    
3.2 Methods (Aim #1a) – Greater Trochanter 
3.2.1 Surgical Procedure  
 Six female Spanish/Boer 
Cross goats ages 4-6 and weight 
30-50 kg were used in Specific 
Aim #1.  Each goat was intubated, 
anesthetized, and prepared for 
sterile surgery using aseptic 
techniques.  Site preparation 
included trimming the hair from 
the incision area, approximately 
15-20 cm circumferentially around 
the greater trochanter of the femur, and removing any remaining hair from the site using a 
depilatory (Veet
®
; Persippany, NJ), applied for approximately 6 minutes.  After rinsing away the 
depilatory and drying, the site was sterilely prepped using an iodine Duraprep sponge stick 
(Cardinal Health; Dublin, OH) and draped with Ioban (Cardinal Health; Dublin Ohio).  Under 
balanced oral endotracheal anesthesia (isoflurane), each hip was exposed through a 5 cm incision. 
A thin flake of bone was removed laterally off of the greater trochanter with a power saw to 
provide a planar surface (See Figure 7).  A porous titanium implant was attached to the greater 
trochanter of each femur of each goat.  The porous metal implant, 15 mm by 20 mm by 35 mm 
(Figure 8) was fixed to the planar surface with two 2.7 mm diameter screws.  
Figure 7. Flake of bone indicated by left arrow.  Planar surface 
for implant indicated by right arrow.  
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 On one side (control, or no-therapy side) of 
each animal, the incision was closed over the implant 
using a 3-0 Vicryl suture. A gauze dressing with a 
clear adhesive film was applied to dress the incision 
site. 
 On the contra lateral side (negative pressure 
therapy side), a Granufoam
®
 polyurethane sponge 
(Kinetic Concepts Inc.; San Antonio, TX) 
approximately 3 cm by 3 cm by 4 cm was sutured to the exposed surface of the implant using 2-0 
Vicryl to ensure constant contact between the sponge and implant.  The wound was not otherwise 
closed.  A clear plastic adhesive film and suction pad (T.R.A.C. Pad™; Kinetic Concepts Inc.; 
San Antonio, TX) was applied to cover the sponge using a typical wound V.A.C.
®
 technique as 
shown in Figure 9.  This sterile semiporous adhesive film maintains negative pressure created by 
the pump.  NPWT was applied using a V.A.C. Freedom
®
 system (Kinetic Concepts Inc.; San 
Antonio, TX) at either -125 mmHg or -200 mmHg.  Dressings were changed as needed to 
maintain an adequate negative pressure seal.  One animal of each level of negative pressure 
treatment was sacrificed at 6, 9, and 12 
days postoperatively (see Table 4).   
Gross observations of tissue adhesion, 
hematoma, fluid filled bursa, fibrinoid 
film formation, and fixation to bone were 
made at necropsy.  Specimens were then 
stored at -80 degrees Celsius to wait 
histological processing.   
Figure 8. Porous metal soft tissue block used 
in Specific Aim #1 
Figure 9. V.A.C.™ Dressing with T.R.A.C. Pad™ 
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3.2.2 Histology 
 The implants and immediately surrounding tissue were retrieved at the time of animal 
sacrifice and stored at -80 degrees Celsius until histological processing.  Specimens were thawed 
and immediately fixed in 10% neutral buffered formalin.  Following fixation, specimens were 
dehydrated in 100% acetone and embedded in Spurr’s Plastic (Polyscience Inc.; Warrignton, PA) 
for sectioning.  The detailed embedding protocol is shown in Appendix C.   
 Sections approximately 500 microns thick were taken perpendicular to the length and 
height of the implant using a Well diamond wire saw (Well Diamond Wire Saws; Norcross, GA).  
Sections were glued to petrographic glass slides using cyanoacrylate and then ground to ~100 
microns thickness using a Buhler grinder with 120, 180, 240, 320, 400 and 600 grit paper.  
Sectioning and grinding protocol can be seen in Appendix D.     
Specimens were embedded and sectioned. The following staining technique has not been 
completed and will be the focus of further study.  Spurr’s Plastic will be removed using an Epoxy 
Resin Removal Kit (Polysciences, Inc.; Warrington, PA) as the initial step in the staining 
procedure.  The slides will be stained using standard Hematoxylin and Eosin (H&E) staining 
techniques and examined quantitatively to determine the depth of penetration and percent 
ingrowth of soft tissue for each animal using the non-therapy specimen as the control.  The 
detailed H&E staining protocol can be seen in Appendix D.   
3.2.3 Evaluation Methods 
 As this was a pilot study, the main objective was to establish valid models for the 
evaluation of the effects of negative pressure on soft tissue growth into large porous titanium 
implants.  The implants for Specific Aim #1 were evaluated qualitatively at the time of implant 
retrieval for apparent tissue adhesion, film formation, hematoma, infection, fluid filled bursa 
formation, and final fixation.  Qualitative data was evaluated either yes or no for the observed 
criteria with exception of apartment tissue adhesion.  Tissue adhesion was evaluated on a -, ±, +, 
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++, with (-) being no visible tissue adhesion and (++) being compete tissue adhesion visible on all 
sides of implant.  Other clinical observations were also noted and recorded in the results.    
3.3 Results (Aim #1a) – Greater Trochanter 
Results were recorded for both Specific Aim #1 and Specific Aim #2.  Qualitative results 
for both aims taken at time of implant retrieval included apparent tissue adhesion, film formation, 
hematoma, infection, fluid filled bursa formation, and final fixation.   
3.3.1  Surgical Procedure and Recovery  
 Six of six surgeries were executed as planned according to the methods Section 3.1.1.  
Animal #1 was the first animal to undergo anesthesia and crashed upon intubation.  The animal 
was resuscitated and allowed to recover before attempting surgery a second time.  Because of 
initial complications with the first attempt at anesthesia, the surgery was modified for this animal 
and the implant was embedded in muscle tissue medial and cranial to the greater trochanter and 
sutured in place just below the level of the epidermis. A transcutaneous sponge was used to apply 
NPWT to one of the implants in the same manner as the other groups.   
 In animal #6, therapy was halted after four days because of inability to reestablish a 
negative pressure seal after it was initially lost and the open wound was allowed to heal by 
second intention until sacrifice at 12 days.   
 Pseudomonas aerugenosa was cultured in goat #3, and gross necropsy findings 
confirmed infection at 8 days post-surgery.  Goats #3 and #4 were sacrificed at 8 and 10 days 
respectively because of suspected infection.   
 Fixation was lost in six of twelve implants and was consistent for each animal.  For 
example, both implants maintained fixation or both implants lost fixation for any given animal. 
3.3.2  Qualitative Results 
 Table 5 outlines the qualitative results obtained from the gross observations of the 
specimens at the time of necropsy for the six animals in the study.  Five of six animals 
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demonstrated improved tissue adhesion to the implant under NPWT compared to the control 
implant with four of the six therapy implants demonstrating good tissue adhesion.  A fibrinoid 
film formed around three of the control implants while no film formed around any of the therapy 
implants.  Two of six control specimens and one of six therapy specimens had a hematoma in 
contact with at least part of the implant.  A local infection was suspected in two of the therapy 
implants.  It was observed that a fluid filled bursa formed around five of six control implants 
while no bursa formation was observed around the therapy implants.  Fixation was maintained for 
six of twelve implants and was consistent on both sides for each animal.   
Table 5. Specific Aim #1, qualitative results taken at time of implant retrieval. 
Animal Specimen
Actual Time of 
Sacrifice (days) 
Tissue 
Adhesion
Film 
Formation Hematoma Infection
Fluid Filled 
Bursa
Maintained 
Fixation
#1, 6 days at 125 mmHg No Therapy 6 - No No No No No
#2, 6 days at 200 mmHg No Therapy 6 - No No No Yes No
#3, 9 days at 125 mmHg No Therapy 8 - Yes Yes No Yes Yes
#4, 9 days at 200 mmHg No Therapy 10 - Yes Yes No Yes No
#5, 12 days at 125 mmHg No Therapy 12 ± Yes No No Yes Yes
#6, 12 days at 200 mmHg No Therapy 12 - No Yes No Yes Yes
#1, 6 days at 125 mmHg Therapy 6 ++ No No No No No
#2, 6 days at 200 mmHg Therapy 6 ++ No No No No No
#3, 9 days at 125 mmHg Therapy 8 ++ No No Yes No Yes
#4, 9 days at 200 mmHg Therapy 10 ++ No Yes No No No
#5, 12 days at 125 mmHg Therapy 12 + No Yes Yes No Yes
#6, 12 days at 200 mmHg Therapy 12 ± No No No No Yes  
 Supplemental information on each of the six goats in Specific Aim #1. 
 Goat #1 was a 6-day animal with a negative pressure of -125 mmHg applied to the 
therapy side.  Because of anesthetic complications experienced with this animal during the initial 
attempt at surgery, the osteotomies of the greater trochanters were not performed and the implants 
were moved superior and cranial to the femur and embedded in muscle tissue with the implants 
sutured to soft tissue.  Good tissue adhesion was observed on the medial side of the implant 
subjected to negative pressure therapy.  There was no bursa formation on the control side and no 
apparent tissue adhesion.   
 Goat #2 was a 6-day animal with the therapy specimen at 200 mmHg.  Surgical 
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procedures were executed according to protocol.  It was observed at time of sacrifice that both 
implants had lost fixation.  Optimal tissue adhesion was visible on the therapy side.  On the 
control side, a fluid filled bursa developed around the implant and there was no visible tissue 
adhesion.  Following surgery, the goat experienced decreased rumen mobility from lack of 
ambulation and a bedsore developed over the control implant.   
 Goat #3 was a 9-day animal with the therapy specimen at 125 mmHg.  The animal was 
sacrificed at 8 days due to early signs of infection.  Fluid cultures taken from the therapy side at 
time of sacrifice tested positive for pseudomonas aerugenosa.  The therapy specimen showed 
visible tissue adhesion while the control side developed a thin membrane and bursa filled with an 
aromatic fluid consistent of pseudomonas.  Both implants maintained fixation to bone.   
 Goat #4 was a 9-day animal with the therapy specimen at 200 mmHg.  The animal was 
sacrificed at 10 days (intended to be a 12-day animal) because of early clinical signs of infection 
and tested positive for pseudomonas aerugenosa although no clinical signs of infection were 
observed during the dissection.  Both implants lost fixation by the time of sacrifice.  Optimal 
tissue adhesion was observed on the therapy specimen.  A thin membrane and fluid filled bursa 
was observed around the control specimen.  The observed fluid was not odoriferous.  
 Goat #5 was a 12-day animal with the therapy specimen at 125 mmHg.  Both implants 
maintained fixation.  Some tissue adhesion was visible on therapy specimen and there was no 
bursa formation or excess fluid.  A thin membrane was observed around the control implant, 
similar to the control specimens on goats #3 and #4, with some tissue adhesion.  A fluid filled 
bursa was observed around the control implant.   
 Goat #6 was a 12-day animal with the therapy specimen at 200 mmHg.  Both implants 
maintained fixation.  Therapy was removed after 4 days of treatment because a proper seal could 
not be obtained once the original bandage was removed.  A fluid filled bursa formed around the 
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control implant with little to no tissue adhesion.  Little tissue adhesion was visible on the therapy 
specimen and there was no bursa or excess fluid around the implant compartment.  
3.4 Discussion (Aim #1a) – Greater Trochanter 
Based on the qualitative results from Specific Aim #1a, there does not appear to be a 
relationship between the use of NPWT and hematoma formation or the maintenance of fixation.  
Despite small numbers, there may be relationships between the use of NPWT and tissue adhesion, 
fibrinoid film formation, fluid filled bursa formation, and infection.  Loss of fixation in 6 of 12 
implants and hematoma formation in 3 implants can most likely be attributed to surgical 
technique and implant location, which is discussed in the following Chapter 4.   
Qualitative results for Specific Aim #1a taken at the time of implant retrieval revealed 
that 6 of 6 implants showed improved tissue adhesion to the porous titanium implant (See Figure 
10 and Figure 11).  These results provide preliminary evidence that NPWT may improve tissue 
adhesion to porous metal implants.  NPWT used in combination with an internal fixation device 
could be promising to speed soft tissue growth to the surfaces of the implant.  Rapid soft tissue 
growth around an implant would be advantageous by preventing the colonization of bacteria on 
the surfaces of the implant.  Of concern however, is the potential for NPWT to create an 
anaerobic environment in a deep closed wound if excess fluid is not removed.  While studies have 
shown that a level of bacteria can be present inside a negative pressure dressing without causing 
infection, more evaluation would need to be done to evaluate such use in an infectious model.   
One unexpected observation was the formation of a fibrinoid membrane (shown in Figure 
10) in three of the control implants. This fibrinoid membrane may also be related to the formation 
of a fluid filled bursa around 5 of 6 of the control implants in Specific Aim #1 despite different 
time points or level of negative pressure.  This apparent film appeared to seal off the surrounding 
soft tissue from growing into the porous implant.  While the cause is unknown, the fibrinoid film 
may be attributed to the movement of the surrounding musculature around the implant, further 
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discussed in Chapter 4.  The fibrinoid film can be seen in Figure 10 and good tissue adhesion is 
shown in Figure 11. Without negative pressure therapy to firmly hold the surrounding soft tissue 
to the implant, the body may have been protecting itself from the rough surfaces of the implant by 
covering the implant with this fibrinoid material, so the surrounding soft tissue could freely move 
around the implant without causing irritation.  Three out of five of the implants surrounded by a 
bursa had a fibrinoid film around the implant as well.  Isolation of the implant for more free 
movement of the surrounding tissue would also explain the bursa formation around five of six of 
the control implants.  We believe that a bursa did not form around the therapy implants because 
the NPWT initially stabilized the tissue surrounding the implant, allowing tissue attachment and 
preventing tissue irritation.   
 Several complications were ascribed to technical problems with negative pressure 
therapy.  The adhesive film did not adhere well to goatskin and hair growth was rapid enough to 
create air leaks in the dressings after three days. In addition, animal temperament varied making 
maintenance of negative pressure dressings difficult with some animals, as was the case in goat 
#6.  Finally, maintaining cleanliness of the dressings and implant fixation was difficult due to 
implant location.   
Figure 11. Goat #3, 8 days at 125 mmHg, therapy 
specimen.  Yellow arrow pointing to apparent  good 
tissue adhesion. 
Figure 10. Goat #3, 8 days at 125 mmHg, control 
specimen.  Yellow arrow pointing to apparent 
fibroid membrane. 
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 To obtain initial sealing of the adhesive dressing, the surgical site surrounding the 
implant had to be shaved and a depilatory used to remove excess hair.  In addition, Adapt
®
 stoma 
paste was used to seal any creases that may have been in the dressing.  After seven days, 
sufficient hair growth had taken place to interfere with adherence of the adhesive drape making 
continued application of NPWT difficult without redepilatating the skin around the incision.  For 
this reason, a less hairy animal, possibly a pig, would be preferred to examine NPWT in the 
future.  
 In addition, animal temperament in reaction to the NPWT made initial recovery difficult.  
Some animals were up and walking normally within hours of surgery while others were not so 
quick to recover.  Whether from the surgery itself, the harness that was used to carry the pump, or 
stress, some animals were not as eager as others to walk following surgery and this resulted in 
poor rumen and digestive function.  To combat the decreased digestive function that was seen in 
Specific Aim #1, a probiotic was used in Specific Aim #2 and is recommended following any 
surgical procedure or other stress related activity such as transport of ruminants. 
 The use of NPWT also appeared to have an increased incidence of infection.  The two 
infections were both suspected in the therapy implant.  Infection however, may have little to do 
with the therapy itself and more to do with maintaining cleanliness of the open wound in an 
animal model.  Local infection was suspected in two of the therapy specimens in Specific Aim #1 
with one confirmed by clinical observation and culture.  With the implants placed on the femur, 
the animal was able to lay in its own feces and urine, soiling the bandages and dressings.  
Maintaining hygiene around the surgical site is one difficulty involved with using an animal 
model.  One would not expect simple care and cleaning of a surgical site to be such a hazard if a 
similar therapy were used in a human application.  For hygienic reasons and maintaining a clean 
bandage, it is recommended that the location of future soft tissue studies be moved from the 
femur to the iliac crest.  Advantages include easier access for the changing of bandages as well as 
34 
 
ease of maintaining cleanliness of the bandages and dressings.  This alternative location is 
discussed more in Chapter 4. 
Poor cleanliness of the surgical site may have led to infection; however, accurate 
detection of early infection was difficult in these animals for both Specific Aim #1 and Specific 
Aim #2.  With different temperament between animals, it was difficult to tell if an animal was 
showing signs of distress as a result of the surgical procedure or from an early infection.  Swab 
cultures proved ineffective as there was a normal environmental presence of pseudomonas 
aerugenosa that would result in a positive culture whether or not an animal showed any clinical 
signs of infection.  This leaves one infection in Specific Aim #1 and one infection in Specific 
Aim #2 in question, both of which showed no clinical signs of infection.  The one animal in the 
therapy group of Specific Aim #2 that was euthanized at 3 weeks due to infection developed an 
open lesion that produced pus, an obvious clinical sign of infection.  Upon opening the incision 
along the plate, the infection ran the length of the plate with pus.  Despite the infection, after an 
initial spike in temperature of 103.5 
○
F the day the lesion was first noticed, the temperature 
dropped back to within normal the following day.  The goat was able to compartmentalize the 
infection and probably could have survived much longer; however, the implant had been 
compromised at that point and the animal was euthanized according to protocol.  Better methods 
to monitor for infection would be of benefit in future studies. 
 Fixation failure in half of the implants (6 of 12 implants) in Specific Aim #1 was ascribed 
to small screw diameter, constraint of screw placement, and implant location. Bone quality at the 
chosen site was less than expected when the implant was designed. This made small diameter 
cortical screws somewhat ineffective for the location that was used.  In addition, location of the 
femur on that lateral side of the animal may have attributed to loss of fixation in some cases.  The 
implants protruded from the lateral surface of the femur making it easy for the goats to fall or lay 
on the implants, which in combination with the small screw diameter may have caused loss of 
35 
 
fixation.  In the future, a larger diameter screw should be used to improve the overall strength of 
fixation.    
 While multiple complications occurred including maintaining fixation, maintaining 
cleanliness (related to infection), and movement of the surrounding soft tissue, these are all 
implant site related.  To resolve these issues, we proposed changing the implant location for the 
study of soft tissue from the femur to the iliac crest.  Two animals were piloted using the iliac 
crest and produced better results with fewer complications.  These two pilot animals and how the 
iliac crest provides a better location for a soft tissue, non-load bearing study are discussed in 
detail in Chapter 4. 
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Chapter 4 Specific Aim #1b (Soft Tissue Model) – Iliac Crest  
 Multiple concerns arose during the study for Specific Aim 1 created by the location of the 
implant as well as the unpredictability and variability of the temperament of each animal.  Three 
animals lost fixation of both implants which could have been created by a high impact force, such 
as falling on their hip/implant following surgery.  Loss of fixation also could have occurred from 
lower impact forces, such as repeatedly laying on their hip and putting pressure on the implant.  
In addition to implants losing fixation, the proximity of the incisions to the perineum of the 
animal and the ground when lying down increased the risk for infection of the incision site.  
Lastly, the muscle surrounding the femur is very mobile during ambulation causing movement of 
the tissue across the protruding implant.  The movement of the muscle tissue across the implant 
surface is not ideal and could have been a contributing factor to observed bursa formation.  
 In response to these concerns that arose from Specific Aim #1, two pilot animals were 
completed in parallel with Specific Aim #2.  The purpose of these 2 pilot animals was to test the 
feasibility of using an alternative location of the iliac crest for placement of the granulation tissue 
block implant.   
4.1 Methods (Aim#1b) – Iliac Crest 
 For these 2 goats, the IACUC approved 
an addendum to the original protocol.  All 
presurgical, surgical, and postsurgical 
procedures remained the same as those of 
Specific Aim #1 with exception of the implant 
location.  The implant location was moved 
from the greater trochanter of the femur to the 
iliac crest (See Figure 12).  NPWT was 
applied in the same manner as specific Aim 
Figure 12. Bilateral iliac crest before closure on the 
control side and application of negative pressure on 
the treatment side. 
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#1a.  Negative pressure dressings were changed every three days.  One animal was sacrificed 2 
weeks after surgery and the other animal was sacrificed 4 weeks after surgery.  
4.2 Results (Aim #1b) – Iliac Crest 
 Gross observation results of the iliac crest were favorable and presented multiple 
advantages over using the femur.  Because the iliac crest is where many muscles are anchored, 
there is less mobility of the surrounding tissue.  With stationary anchor points surrounding the 
implant, the iliac crest provides a more favorable environment for soft tissue growth into the 
implant.  The lack of mobility of the surrounding tissue as well as not having to lie on one of the 
implants also appeared to cause less discomfort to the animal.   The location is higher off of the 
ground and away from the perineum of the animal improving cleanliness of the surgical sites and 
also making dressing changes easier.  The animals exhibited no signs of infection.  Lastly, the 
dorsal location of the implants means that the animals cannot fall or lay on the implants.  Both 
implants maintained fixation for the entire 2 or 4-week duration of the study.    
 In the iliac subjects and the gluteal subject without screws, better responses to therapy were 
noted than in the trochanteric subjects. The 6-day gluteal subject showed better soft tissue 
attachment than did the trochanteric ones at longer intervals. This was ascribed to less gliding of 
the skin and soft tissue over the more prominent trochanteric implant.  
 The 2-week iliac subject showed the most clearly defined contrast between the open wound 
with therapy, and the uncomplicated closed wound with no therapy. The no therapy side showed 
a dark red-brown triangular section mass just lateral to the periosteum, about 1.5cm on each side. 
This was grossly consistent with edematous muscle and/or organizing hematoma. The same area 
on the open wound/therapy side showed dense, dry, white early scar without inflammation.  
 The 4-week iliac goat showed a similar degree of maturation of the soft tissue attachment 
between the therapy and no-therapy sides. There may or may not have been some skin ingrowth 
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on the open, therapy side (See Figure 13). There was no bursa formation on the no-therapy side. 
The gross appearance suggested that the no therapy side had “caught up” with the therapy side at 
the 4 week interval.  
4.3 Discussion (Aim #1b) – Iliac Crest 
One limitation of the two animals that were 
piloted using the iliac crest as the implant location was 
how the implants were closed.  The implant on the 
control side was completely closed over while the 
therapy implant remained transcutaneous in order to 
apply negative pressure therapy.  To overcome this for 
future studies, an alternative method of negative 
pressure therapy application would need to be 
developed in order to maintain consistency of closure 
over the implant. 
Based on the observations of these 2 animals, the iliac crest is a superior location for this 
type of study and is recommended for future studies of soft tissue growth into large porous metal 
implants.  
 
Figure 13. Ingrowth implant applied to iliac 
crest and transcutaneous with negative 
pressure therapy for 4 weeks.  Note open 
pores and skin attachment. 
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Chapter 5 Specific Aim #2 (Bone Growth Model) – Tibia 
 An in vivo caprine model was used to assess bone ingrowth.  Goats were chosen because 
of their similar bone size to that of human as well as successful development of the model by 
other research groups (AFIRM).  Ten Spanish/Boer cross goats, ages 4-6 and weighing 40-60 kg, 
were used for Specific Aim #2.  Two goats served as pilot animal to evaluate the surgical 
procedure and husbandry needs and the remaining 8 goats were divided evenly between the 
therapy and control groups.  Breakdown of the research groups for Specific Aim #2 can be seen 
in Table 6.  A tibia segment implant to be made of porous titanium implants was designed to 
deliver NPWT through the implant to the surrounding soft tissue.  Design of this implant is 
described in following section.  The Animal Care and Usage Protocol (ACUP), describing the use 
of animals in this study, was approved by the Institution For 
Animal Care and Usage Committee (IACUC). The medications 
used for this study along with their purposes and dosing 
information can be found in Appendix A. 
5.1  Implant Design (Aim #2) – Tibia 
 This section describes the design process for the first two implant designs that were piloted 
and how we decided on the implant that was used for the study. 
 The tibia segment implant was designed to evaluate the effects of 
NPWT in promoting bone and soft tissue growth into porous titanium 
implants.  Wright Medical, Inc. agreed to supply the tibia segment 
implants, at machining cost, made out of their porous titanium, 
BIOFOAM™ material.  The original design specified a 25 mm diameter 
by 35 mm tall cylinder.   
 A 3-D model of the first tibia segment implant can be seen in Figure 14.  The planes of 
Table 6. Specific Aim #2 
animal groups 
Figure 14. Tibia segment 
implant. 
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both ends were inclined 15° in order to increase compression between 
the bone/implant interfaces as the screws of the construct are tightened.  
In addition, the inclined planes prevent the implant from sliding out from 
between the two bones on the opposite side of the plate.  A screw hole 
was also added to the middle of the implant for a screw to hold the 
implant against the plate and align the implant rotationally.  For the 
second pilot animal, a 4 mm diameter through hole was added the length of the implant (Figure 
15) for a channel drain.  This change would more directly apply suction through the porous metal 
implant.   
 Hardware for the tibia segment procedure was purchased from Veterinary Orthopedic 
Implants (VOI).  For the two pilot procedures, a 6 hole, 14 mm width, compression plate was 
chosen.  This width of plate was recommended by VOI for the size of goats chosen for this study.  
This fixation method, using only 4 screws, was deemed insufficient after two unsuccessful 
bilateral pilot animals. The middle two holes were covered by the implant and therefore not used.  
A hole was added in the center of the plate for a screw to hold the cutting guide in place and, once 
the implant was in place, for a 16 mm long, 4.5 diameter screw to screw the implant to the plate.    
 For the surgery, 4.5 mm diameter screws ranging from 22 mm to 36 mm were made 
available, 4 of which were used for each tibia based on measurement with a depth gage.  For the 
first pilot animal, self-tapping screws were used which added time to the surgery and were 
deemed inadequate.  A tap, purchased from VOI, was used in the second pilot improving ease of 
surgery and decreasing operation time.    
 Also needed for the tibia procedure was a cutting guide to assist in making accurate, 
reproducible angled cuts to properly fit the implant.  A prototype was machined in the lab out of 
aluminum and bench tested before was a final guide was machined out of stainless steel by an 
Figure 15. Tibia 
segment implant with 
through hole. 
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outside machine shop.  The cutting guide was designed to be 
screwed into the bone over the plate while the cuts are being 
made.  A 3-D image of the cutting guide can be seen in Figure 
16.     Figure 17 shows the cutting guide in use on a goat tibia.  
  Following two unsuccessful pilot surgeries, one from 
anesthesia complication and the other due to the animal’s 
inability to walk following surgery from 
the bilateral procedure, the one plate 
method using fours screws was 
determined to provide inadequate 
fixation.  The implant was redesigned to 
be a traditional cylinder, 20 mm diameter 
by 35 mm long (Figure 18) in order to 
reduce the complexity of the surgery and 
a new fixation technique using two plates in an orthogonal arrangement 
(Figure 19) was used to improve stability.  A machine screw (8-32) 
instead of a bone screw was also used to hold the implant to the long 
plate.  This method is described in detail in the surgical methods 
Section 5.2.1.   
5.2 Methods (Aim #2) – Tibia 
5.2.1 Surgical Procedure 
 Eight female Spanish/Boer Cross goats ages 4-6 and weight 30-50 kg were used in 
Specific Aim #2.  All orthopedic screws and plates were purchased from Veterinary Orthopedic 
Implants (V.O.I.; St. Augustine, FL).  A list of surgical instruments, hardware, and supplies can 
Figure 17. Cutting guide in use. 
Figure 18. Final tibia 
segment implant design, 
straight cylinder. 
Figure 16. Tibia segment cutting 
guide. 
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be found in Appendix E.  A center hole was added to the 12-hole plate to attach the implant to the 
plate using a stainless steel machine screw (8-32).  This hole with machine screw can be viewed 
in Figure 19.  All screw lengths were measured with a depth gage and rounded up to the nearest 2 
mm.    
 Each goat was 
intubated, anesthetized, and 
prepared for sterile surgery 
using aseptic techniques. Site 
preparation included trimming 
the hair from the incision area 
and removing any remaining 
hair from the site using a 
depilatory (Veet
®
 Parsippany, NJ), applied for approximately 6 minutes.  After rinsing and 
allowing to dry, the site was sterilely prepped with an iodine Duraprep sponge stick (Cardinal 
Health; Dublin, OH) and the leg sterilely draped with Ioban (Cardinal Health; Dublin Ohio). The 
side that was chosen for the procedure was alternated with each surgery.   
 Under balanced oral endotracheal anesthesia, one tibia was exposed through a medial 
incision approximately 10 cm in length beginning just proximal of the distal joint of the tibia.  
The periosteum was circumferentially separated from the tibia along the tibia shaft with a Cobb 
Elevator.  The porous metal implant, 20 mm diameter by 35 mm length (Figure 20) was soaked in 
a heparin solution of 10 mL of saline mixed with 1 mL Heparin (10,000 units/mL) to keep the 
implant patent throughout the duration of the surgery.   
Figure 19. Completed tibial osteotomy construct 
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 The 12-hole plate was fitted to the 
medial surface of the tibia using plate benders 
when necessary.  A bicortical screw was drilled, 
tapped, and tightened in the center hole of the 12-
hole plate (a countersunk center hole was added 
to the center of the plate to fit an 8-32 machine 
screw used to secure the implant to the plate).  
Pockmarks were made in the 4
th
 hole from center 
on both sides of the plate to be used for alignment following the osteotomy.  The slotted plate was 
aligned on the posterior surface of the tibia and two screws in the proximal hole and two screws 
in the distal hole were drilled, tapped, and loosely tightened being careful to avoid the screw 
holes in the 12-hole plate and where the implant would go.   
 All but the most proximal screw in the slotted plate was removed.  The slotted plate was 
rotated out of the osteotomy site and the cutting guide was screwed into place with a bicortical 
screw.  After aligning the cutting guide with the 12-hole plate, a second screw was put into the 
guide to prevent rotation during sawing.  The osteotomy was performed using a power saw; the 
distal cut was followed by the proximal cut, being careful to stay alligned with the cutting guide.   
 The slotted plate was then realigned and the four screws were loosely screwed into the 
previously drilled holes. The implant was loosely screwed to the 12-hole plate using a ¾”, 8-32 
stainless steel machine screw and aligned using the previously drilled pockmarks.  A screw was 
eccentrically drilled, tapped, and tightened in the third hole proximal from center to apply 
compression between the proximal segment of bone and implant interface.  Screws were 
centrically drilled, tapped, and tightened in the 4 remaining unused proximal holes.  
Figure 20. Porous metal tibial implant used in 
Specific Aim #2 
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 The distal end of the tibia was aligned with the 12-hole plate and a Verbrugge clamp was 
used on the screws in the slotted plate to compress the interface between the distal bone and the 
implant.  If necessary, a second Verbrugge clamp was used to compress the distal end of the plate 
to the tibia.  With compression applied, a screw was eccentrically drilled, tapped, and tightened in 
the third hole distal from center to apply compression between the distal segment of bone and the 
implant interface.  With compression still applied, the most proximal and distal screws in the 
slotted plate were fully tightened.  After removing the Verbrugge clamps, the two remaining 
screws in the slotted plate were fully tightened. Screws were centrically drilled, tapped, and 
tightened in the 4 remaining unused distal holes. 
 All 8 tibiae were prepared in the previously described manner.  The animal groups for 
Specific Aim #2 can be seen in Table 5.  For the four control animals, a channel drain was placed 
next to the implant and the incision was sutured closed with 3-0 Vicryl in a running suture 
pattern.  The drain exited the body through a poke hole approximately 3 cm posterior of the 
incision and the drain tube attached to an external bulb to remove excess fluid for 48 hours or 
until the wound stopped producing fluid.   
For the 4 therapy animals, a T.R.A.C. Pad™ was placed under the periosteum on the 
lateral surface of the implant.  The T.R.A.C. Pad™ was secured on the posterior-lateral side of 
the implant with two 2-0 Vicryl sutures that went around the implant connecting both sides of the 
T.R.A.C. Pad™.  The tube was brought through the skin through a poke hole approximately 3 cm 
posterior of the incision.  Two interrupted sutures were used to close the poke hole around the 
tubing.  The incision was then closed using a 3-0 Vicryl suture in a running suture pattern, 
providing an airtight seal. Negative pressure therapy was then applied to the implant using a 
Freedom V.A.C. Freedom
®
 (Kinetic Concepts Inc.; San Antonio, TX) system at -125 mmHg for 3 
days or until therapy was no longer feasible.  Therapy times varied within this time period (24-72 
hours) in order to determine how long negative pressure therapy could be maintained when 
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applied in this manner.  Coagulation of blood in the 
tubing would cause the pump to shut down when 
negative pressure could no longer be maintained.  
Pump error messages along with troubleshooting 
methods can be seen in the V.A.C. Freedom
®
 Alarm 
Troubleshooting Quick Reference guide in Appendix 
F. The goats recovered from anesthesia in a partial 
weight bearing sling (Figure 21) until the animals 
regained leg control. The pump was carried by the 
animal in a custom harness that can be seen in Figure 
22.  Two animals for each group, therapy and control, 
were sacrificed at each time point, 6 and 12 
weeks (see Table 6). 
 Each animal underwent the 
fluorescent staining regimen described in 
Section 5.2.2.  Throughout the time period of 
the study, each animal’s gait was graded with 
the following gait score [33]; 0 = not used at 
all, 1 = supported incidentally, 2 = loaded in a standing position and incidental while walking, 3 = 
loaded in a standing position and while walking but with a limp, and 4 = normal while walking 
and standing.  Animal records that were kept following surgery include gait, medications, weight, 
therapy duration, temperature, and pre-surgery physical vet approval.  Observation sheets can be 
seen in Appendix G.  At the time of necropsy, tibia constructs were evaluated grossly for bone 
growth, tissue adhesion, hematoma, fluid filled bursa, fibrinoid film formation, and fixation to 
Figure 21. Partial weight bearing sling 
used during animal's initial recovery from 
surgery. 
Figure 22. Goat harness used to carry pump. 
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bone.  Tibia constructs were then mechanically tested according to the procedure described in 
Section 5.2.3 and will undergo histological analysis as a part of further study.  
5.2.2 Fluorescent Staining Regimen 
 Every animal in Specific Aim #2 underwent a fluorescent staining regimen for the 
duration of the study. Three fluorescent stains, calcein, oxytetracycline, and xylenol orange were 
chosen for this study based on staining characteristics.  Stains were administered every 2 weeks 
via injection according to the protocol.  Animals sacrificed at 6 weeks received an injection at 2 
and 4 weeks while animals sacrificed at 12 weeks received an injection at 2, 4, 6, 8, and 10 
weeks.  Mixing directions for the calcein and xylenol orange injection are given in Table 7.  
Oxytetracycline is a common antibiotic and was purchased in injectable form.  Dosing 
instructions for each stain are given in Table 8. 
Table 7. Fluorescent stain injection preparation mixing directions 
Calcein Green (Sigma-Aldrich, Product #C0875) 
To make 50 mg/mL solution: 
 Total Amount:     10 mL  
 Calcein (Sigma # C0875)                              500 mg 
 NaHCO3 (Fisher #233-500)  500 mg 
 Sterile Saline    10 mL 
 Directions: Stir covered until dissolved. Store at 4
○
 C in the dark for no more than 1 week.  
Remove from refrigeration ½ hour before administration. 
Xylenol Orange ACS reagent (Sigma Aldrich, Product #398187) 
To make 90 mg/mL solution: 
Total Amount:     50 mL  
 Xylenol (Sigma # C0875)                 4500 mg 
 Sterile Saline    50 mL 
 or 1.4% isotonic NaHCO3                 50 mL  
Directions: Dissolve in physiological saline or in 1.4% isotonic NaHCO3 at a concentration up to 
90 mg/mL. Can be stored at 4
○
 C for several weeks.  
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Table 8. Fluorochrome stain recommended dosing 
Stain 
Solution 
Concentration 
Dosing 
Volume (50 
kg animal) 
Method of 
Administration 
Administration 
Time 
Calcein Green 50 mg/mL 
10-30 
mg/kg 
10-30 mL SQ 
2 weeks and 8 
weeks 
Oxytetractcline 
(yellow) 
200 mg/mL 
20-25 
mg/kg 
6.25 mL IM 
4 weeks and 10 
weeks 
Xylenol Orange 90 mg/mL 
90 
mg/kg 
50 mL SQ 6 weeks 
 
5.2.3  Mechanical Testing 
 All specimens in Specific Aim #2 were tested for biomechanical strength using a similar 
method to the one found in the study performed by Bullens et al. [33].  After the removal of all 
excess tissue from the tibia, the ends of both the operated and contra-lateral tibiae were embedded 
in polymethyl methacrylate (Patterson Dental, St. Paul, MN) so that the former defect located in 
the center was free with a margin of 3-cm on the proximal and distal sides of the osteotomy site.    
The 12-hole plate was removed before potting.  The slotted plate was left in place, and its screws 
were removed just before testing to prevent damage to the construct during the potting process. 
The specimens were mounted on a Materials Testing System machine (MTS System Corporation; 
Eden Prairie, MN) so that external torsion was applied to the distal end while the proximal end 
was free to translate on an x-y table.    The x-y table was used to compensate for any off axis 
alignment.  A “zero” load control was used to maintain an axial force of 0 N during the duration 
of the test.  All tibiae were tested for load to failure at a rate of 2 degrees per second to simulate a 
dynamic loading condition [40]. Torque at failure (maximum torque) was selected to reflect 
torsional strength and was expressed as a percentage of torque at failure (maximum torque) 
relative to the contra-lateral (non-operative) leg of the same animal.  Therefore, a percent 
torsional strength of 100% is the same torsional strength as the non-operative leg.  In order to 
preserve the specimens for histological testing, mechanical testing was automatically stopped 
immediately after fracture or failure indicated by a clear audible sound and drop in mechanical 
strength to 40% or less.  A potted and mounted tibia is shown in Figure 23. 
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 All mechanical testing was performed within 36 
hours of sacrificing the animal.  Specimens were stored at 4 
degrees Celsius until mechanical testing and kept moist with 
saline wetted gauze sponges until mechanical testing.  All 
mechanical testing was performed using a MTS 858 Mini 
Bionix II testing system.  An Axial-Torsional Load 
Transducer with an axial capacity of 15 kN and torsional 
capacity of 150 Nm was used at full scale.  Data was 
recorded at 100 Hz to 4 decimal places and reported to 2 
decimal places.   Following all biomechanical testing, 
specimens were stored at -80 degrees Celsius until histological processing.   
5.2.4 Histology Preparation 
Specimens from Specific Aim #2 were prepared in the same manner as specimens from 
Specific Aim #1.  For specifics, refer back to Section 3.2.2.  Histological analysis is outside the 
scope of this thesis and will be the focus of further study. 
5.2.5 Evaluation Methods 
Qualitative evaluation in Specific Aim #2 had similar categories to Specific Aim #1 
including apparent tissue adhesion, film formation, hematoma, infection, fluid filled bursa 
formation, and final fixation.  In addition, the implants for Specific Aim # 2 were evaluated for 
apparent bone ingrowth and biomechanically tested for ultimate torque.  At 6 and 12 weeks, all 
implants had excellent tissue adhesion, so the type of tissue was noted instead of the -. ±, +, ++ 
scale.  For bone growth, the -, ±, +, ++ was used with the following criteria: 
Qualitative bone ingrowth scale: 
(-) = no apparent bone growth  
(±) = callous growth 
(+) = callous growth with minimal bone growth 
(++) = excellent bone growth 
Figure 23. Biomechanical testing 
setup. 
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In addition to qualitative results taken at the time of implant retrieval, the ultimate torque 
for each tibia was recorded as the measure of strength.  The strength for each segmental tibia 
construct was expressed as a percentage of the ultimate torque of the contra lateral, unfractured 
tibia.  Clinical observations for each animal were recorded as well.   
5.3 Results (Aim #2) – Tibia 
For Specific Aim #2, apparent bone growth was recorded in addition to all the previous 
categories from Specific Aim #1.  Quantitative results were recorded for biomechanical strength 
for Specific Aim #2.   
5.3.1 Surgical Procedure and Recovery 
 Two pilot animals were used to test and refine the surgical techniques and post-surgery 
husbandry care.  The first pilot animal made it through surgery without any surgical 
complications but did not recover from anesthesia and therefore the animal’s tolerance of a 
bilateral procedure could not be evaluated.  The cause of death was determined to be prolonged 
operative time (> 5.5 hours) and a pancurium overdose.  The second pilot animal made it through 
the surgical procedure and recovered from anesthesia but was euthanized 8 days following 
surgery because of prolonged signs of pain and intolerance.  The animal would not walk on a 
regular basis and gastric functions never fully recovered following surgery.  The tibia construct 
(Figure 19) was deemed inadequate and was redesigned to the construct described in Section 5.1.   
 The four control animal surgeries went as planned with no complications from fixation or 
infection. Even though goat #9 showed signs of ringworm, 2 small lesions, 10 weeks after 
surgery, this was deemed unrelated to the study and did not affect the results.  Goat #9 was 
sacrificed at 12 weeks as planned. 
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 Of the therapy animals, goats #11, #13, and 
#14, had no surgical complications during the 
procedure.  NPWT was applied to the four therapy 
animals for 24 to 72 hours (until pump would no 
longer run due to pump error).  Actual therapy 
durations are given in Table 9. Therapy times 
varied, from 23.35 hours to 70.79 hours, to 
determine how long negative pressure therapy 
could be maintained.  Coagulation of blood in the tubing would eventually lead to loss of therapy 
turning the pump off.  Therapy was discontinued when therapy could no longer be maintained.  
For future studies the therapy duration should remain consistent.   
Goat #12 had two surgical complications.  The first complication was that the proximal 
cut of the osteotomy was not parallel to the distal cut.  To correct this, an additional 2 mm 
segment of bone was  taken out of the proximal end of the tibia to make the bone end better align 
with the proximal end of the implant.  The second complication was insufficient fixation in the 
proximal screws of the slotted plate.  This was resolved through the use of a cerclage wire around 
the proximal end of the plates.  This animal was later euthanized 3 weeks following surgery 
because of a small infection in the proximal end of the surgical incision where the cerclage wire 
had created a poke-hole.  The issue could not have been resolved without a follow-up surgery to 
correct the cerclage wire.   
 Goat #11 developed an infection approximately 2 weeks following surgery and was 
euthanized 3 weeks following surgery after an attempt at resolving the infection was 
unsuccessful.  Upon dissection, a pseudomonas aerugenosa infection ran the length of the plate 
and had formed a white/yellow pus material beneath the incision line.  This infection was 
confirmed through culture.   
Animal Number Therapy duration
Goat # 7, 6 week control 
Goat # 8, 6 week control 
Goat # 9, 12 week control 
Goat # 10, 12 week control 
Goat # 11, 6 week                     
(3 week due to infection) 30.78 hrs
Goat # 12, 6 week                     
(3 week due to infection) 70.79 hrs 
Goat # 13, 12 week 28.14 hrs
Goat # 14, 12 week 23.35 hrs
Table 9. NPWT durations for each animal 
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 Goat #13 had two similar small lesions on her operative tibia 5 weeks after surgery.  The 
lesions were found on the same day as those found on Goat #9 and were not wet.  Later results 
showed that the lesions on Goat #13 were also from ringworm and unrelated to the study.  
 Overall, there were only two complications, one infection (Goat #12) and one surgical 
complication with the cerclage wire (Goat #11).  The remaining six animals had no complications 
and made it to their respective term completion at either 6 weeks or 12 weeks.   
5.3.2 Qualitative Results 
The qualitative results for Specific Aim #2 taken at time of sacrifice are summarized in 
Table 10.  Bone growth was improved among the control animals sacrificed at 12 weeks over the 
control animals at sacrificed at 6 weeks.  No bone ingrowth was observed in the 2 therapy 
animals that were sacrificed at 3 weeks due to infection.  White, fibrous tissue ingrowth was 
observed in all of the specimens with exception of the two infected implants. No hematoma or 
film formation was observed in any of the implants and only the severely infected specimen 
developed a bursa around the plates and implant.  All implants maintained rigid fixation of the 
tibia construct. The following are the observations for each animal that were taken after 
euthanization and before mechanical testing.   
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Table 10. Qualitative results for Specific Aim #2 
Animal
Bone 
Growth
Tissue 
Adhesion
Film 
Formation
Hematoma Infection
Fluid Filled 
Bursa
Maintained 
Fixation
#7, 6 week control ± Fibrous No No No No Yes
#8, 6 week control ± Fibrous No No No No Yes
#9, 12 week control + Fibrous No No No No Yes
#10, 12 week control + Fibrous No No No No Yes
#11, 6 week therapy                     
(3 weeks due to infection)
- No/Pus No Yes Yes Yes Yes
#12, 6 week therapy           
(3 weeks due to infection)
- No No No Yes No Yes
#13, 12 week therapy ± Fibrous No No No No Yes
#14, 12 week therapy + Fibrous No No No No Yes
 
 Supplemental information on each of the eight goats in Specific Aim #2. 
Goat #7 was a 6-week control animal.  There were no sign of infection and no hematoma, 
bursa, or film formation was observed.  Bone growth was observed over the middle section of the 
slotted plate.  There was callous formation around the distal end of the implant.  Wear debris was 
observed at the second and third holes proximal from the implant and the most distal hole 
between the plate and bone. 
Goat #8 was a 6-week control animal.  There was no excess fluid or hematoma 
formation.  Bone growth was observed over the proximal and distal ends of the slotted plate with 
callous formation around the proximal end of the implant.  A narrow gap appeared between the 
distal implant/tibia interface on the radiographic image.  No wear debris was evident at any of the 
screw holes. 
Goat #9 was a 12-week control animal.  There was no excess fluid or hematoma 
formation.  Excellent tissue adhesion at 12 weeks, mostly white fibrous tissue, was observed.   A 
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small Gap appeared on radiographic and fluoroscopic images between the proximal end of the 
implant and bone at the time of euthanization.  No infection was evident clinically.  Bone 
formation was most prevalent between the two plates and over the ends of the slotted plate on the 
caudal side of the tibia.  The most proximal screw head in the slotted plate was covered by 
calcification and had to be removed using a ronjeur in order to remove the screw for mechanical 
testing.  Underneath the calcification, wear debris was evident.  Wear debris was also evident 
between the 12-hole plate and bone surface at the second most proximal hole.  The debris did not 
appear to have caused any osteolysis but did affect a small area of the periosteum.   
Goat #10 was a 12-week control animal.  No excess fluid or hematoma formation was 
observed.  We observed excellent fibrous tissue adhesion and apparent good union between 
proximal surface of the implant and bone.  Goat #10 appeared to have more significant bone 
growth than goat #9.  Bone growth was in a location consistent with the other 12-week control 
animal: around the slotted plate and between the two plates.  Prevalent callous and bone 
formation was noted around the slotted plate with the two proximal screws and distal end of the 
plate covered by bone as well as an approximately 3 cm section at the proximal implant/bone 
interface.  The distal screw head of the 12-hole plate was also covered by bone growth.  The tibial 
tuborosity was noted as growing back out over the implant.  A ronjeur was required to remove 
bone growth over the screw heads that were covered in order to remove the screws for 
mechanical testing.  No infection was evident.  There was evidence of wear debris in three screw 
holes in the 12-hole plate: the most proximal and the two immediately distal of the implant. 
Goat #11 was originally a 6-week therapy animal but was sacrificed at three weeks 
because of a pseudomonas aerugenosa infection.  After opening the incision, the infection ran the 
length of the plate and produced pale green pus.  Minimal bone growth had taken place and no 
tissue adhesion.  There was also a fluid filled bursa around the tibia construct, containing the 
infection.     
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Goat #12 was originally a 6-week therapy animal and was sacrificed at 3 weeks as a 
result of a surgical complication.  The cerclage wire that was used proximal of the implant 
created an opening in the groin of the animal.  There was no way to repair this hole without 
another surgery to correct the cerclage wire.  As a result, there was little bone growth and tissue 
adhesion at the time of sacrifice.  There were two hematomas, one over the implant and one 
proximal, where the cerclage wire was used.     
Goat #13 was a 12-week therapy animal.  There was some bone growth between the two 
plates and minimal topical bone growth over and around the slotted plate.  Overall, less bone 
growth was observed in Goat #13 than in either of the 12-week control animals.  There was 
complete fibrous tissue growth into the implant with no hematoma, fibrinoid film, infection, or 
fluid filled bursa formation.  The implant maintained rigid fixation although the 4 screws in the 
slotted plate could be tightened one full rotation.  There was evidence of wear debris in the most 
proximal hole of the 12-hole plate and was limited to the underlying soft tissue.   
Goat #14 was a 12-week therapy animal.  Bone growth was observed between the two 
plates and around the slotted plate including some topical bone growth.  The amount of topical 
bone growth on top of and around the slotted plate appeared to be more than Goat #13 and less 
than Goat #9 and Goat #10.  There was complete fibrous tissue ingrowth with no sign of a 
fibrinoid film, hematoma, infection, or bursa formation.  No screws were found to be loose and 
no wear debris was evident.  
5.3.3 Quantitative Biomechanical Results 
Biomechanical results described below can be seen in Table 11.  Goats #7 and #8, 6-
week control animals, had percent torsion strengths of 3.64% and 0%, respectively.  The 
implanted tibia of goat #7 could not be biomechanically tested because insufficient bone growth 
across the tibia/implant interface left the construct unstable after removal of the 12-hole and 
slotted plates.  Goats #9 and #10, 12-week control animals, had percent torsion strengths of 
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7.99% and 5.93%, respectively.  Goats #11 and #12, 6-week therapy animals, had to be sacrificed 
at 3-weeks because of infection and as a result, there was no stable fixation between the implant 
and bone.  Because of unstable union at the implant/bone interface, the two implants were not 
biomechanically tested. Goats #13 and #14, 12-week therapy animals, had percent torsion 
strengths of 1.60% and 5.36%, respectively.     
Table 11. Biomechanical results for Specific Aim #2 
Animal # 
Implanted Tibia 
Ultimate Torque (Nm) 
Normal Tibia 
Ultimate Torque (Nm) 
Percent Ultimate 
Torque of Implanted 
Tibia (%) 
#7 (6 week control) - 52.23 0 % 
#8 (6 week control) 2.16  59.34 3.64 % 
#9 (12 week control) 4.62 57.84 7.99 % 
#10 (12 week control) 4.23 71.28 5.93 % 
#11 (6 week therapy)  
3 weeks due to infection 
- - - % 
#12 (6 week therapy) 
3 weeks due to infection 
- 47.06 - % 
#13 (12 week therapy) 1.07 66.97 1.60% 
#14 (12 week therapy) 2.94 54.81 5.36% 
 
5.4 Discussion (Aim #2) – Tibia 
Based on the results, there was a trend toward lower percent ultimate torque of the 
therapy group at 12-weeks (3.48% vs. 6.96%) although there are insufficient numbers to establish 
any level of significance.  This is consistent with what was observed with respect to bone 
ingrowth.  Bone growth was most prevalent over and around the slotted plate in the control and 
therapy animals and only after 12-weeks.  Bone growth around the slotted plate is consistent with 
bone growing in the most stable part of the fixation construct.  With the orthogonal arrangement 
of the two plates, the most stable segment of the interface is immediately along the line of the 
slotted plate.  It is possible that the orthogonal plating technique was not stable enough across the 
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entire bone/implant interface to support bone growth across the interface.  A finite element 
analysis of the orthogonal plating construct may reveal more regarding the stresses and strains 
that take place along the implant/bone interface.  
Given that the percentage strengths of both 12-week therapy animals were lower than 
both percentage strengths of the 12-week control animals it appears that negative pressure therapy 
may inhibit bone growth.  The trend is for worse bone growth with the use of negative pressure 
therapy.  With only 2 animals in each group no statistical significance can be established and it is 
possible that the difference between these two groups can be explained by variance of the 
percentage strength within the population of each group.      
One possibility as to why no positive effect of therapy on bone growth was observed 
could be explained by the relatively short duration of negative pressure therapy in relation to the 
time it takes to achieve bone growth and remodeling.  Bone formation and remodeling takes up to 
six weeks in goats, but the negative pressure therapy could only be applied for a small fraction of 
this time (24-72 hours).  Therapy duration varied within this range to determine how long 
negative pressure therapy could be applied in this manner.  It is possible that a longer duration of 
therapy may have a greater impact on bone growth than what was observed in this study.   
For the shorter term therapy group, the two 6-week therapy goats had to be euthanized 
early, at 3 weeks, because of infection.  Because of this early termination, a comparison between 
the control and therapy groups cannot be made at this time interval.  It is possible that NPWT 
increased the likelihood of infection, in which case developing a better method to maintain a 
sterile surgical site in the therapy group should be a priority moving forward.  Similar to Specific 
Aim #1, maintaining a clean surgical site in a human application would not be as much of a 
concern as it is in an animal model.     
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As previously mentioned, a change from Specific Aim #1 that was found helpful during 
Specific Aim #2 to help with animal recovery following surgery was the use of Probios
®
 
following surgery. This probiotic helped these ruminants’ digestive systems recover following 
surgery and is recommended as a regular part of any surgical procedure involving ruminants. The 
dosing was 10 g the evening of surgery and 5 grams two times a day until they were taken off 
buprenorphine.   
Another topic of discussion is the method of application of negative pressure to the 
porous metal implant.  Several methods were attempted during this study.  In Specific Aim #1, a 
piece of sponge was used as a conduit to transmit the negative pressure from the pump through 
the incision down to the implant.  A similar method is commonly used to transmit negative 
pressure along the leg underneath a cast to an open wound on the bottom of the foot.  This 
method appeared to work for a time but eventually, the conduit sponge would lose contact with 
the implant surface or the exterior sponge or both.   
In Specific Aim #2, for the second pilot animal, a hole was bored trough the implant 
along its length to insert a channel drain that would then distribute negative pressure through the 
implant.  This appeared to be an effective method as fluid removal through the implant was 
observed during surgery before incision closure; however, the drain rapidly became clogged in 
approximately 24 hours and could only be removed and not replaced with this method.  Also, the 
cost involved with creating the through hole so as not to clog the pores in the implant increased 
the cost of the implant beyond the feasibility of this study.   
The third method, which was used for Specific Aim #2, was applying the T.R.A.C. Pad™ 
directly to the surface of the implant holding it in place with sutures.  This proved effective and 
remained patent for 24-72 hours and could easily be removed when needed, again however, the 
T.R.A.C. Pad™ could not be replaced if necessary.  Therapy could only be continued as long as 
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the tubing remained patent and there were no pump errors.  Other than pump malfunctions, there 
was no way to monitor patency of the T.R.A.C. Pad™ and tubing.  Pump errors and the V.A.C. 
Freedom
®
 Alarm Trouble Shooting Guide can be seen in Appendix F. 
Also discussed was the possibility of creating a transcutaneous fixture that attached to the 
implant so that tubing could be changed if clogged.  This method could potentially allow for a 
longer application time of NPWT or the instillation of fluids, antibiotics, and growth factors to 
further improve healing.    
There are many possibilities of how to apply negative pressure to distribute the therapy 
through the porous implant.  Computer or bench top models may be a valid method to determine 
the optimal application of negative pressure therapy; however, the main dilemma we faced was 
clogging of the tubing due to coagulation.  Any model would have to take blood coagulation into 
account in order to be useful for application to an in vivo model. Validation of the proper 
application of negative pressure therapy through a porous metal implant, either through a 
computer model, in vitro model, or combination, would be necessary before future in vivo studies 
should be done. 
 
 
 
 
 
61 
 
 
 
 
Chapter 6 Further Discussion 
62 
 
Chapter 6 Further Discussion  
6.1 Limitations 
 There were several limitations in this study with the most obvious being the use of an 
animal model for a human application.  An animal model was necessary to control variables such 
as defect size and location.  For obvious reasons, such as the novelty of this technology and the 
inability to control variables, this research was inappropriate for human study at this point in the 
research.  A caprine animal model was chosen for this study because of comparable bone size 
between goats and humans and its use by other research groups that are a part of AFIRM.  The 
use of an animal model also introduced the additional issue of maintaining a clean wound that 
would not be as difficult of a concern to deal with in a human application.  Humans understand 
that the wound needs to remain clean and that jumping around could damage fixation. Animals 
however, do not understand these issues.   
 Another limitation of this study was the low numbers of animals that were used.  This 
was known upon initiating the study as it was planned to be a preliminary investigative look into 
the use of a novel combination of technologies to repair segmental defects.  Small numbers 
became a further limitation when infection caused the removal of 1 animal from Specific Aim #1 
and 2 animals from Specific Aim #2.  If a technology combining negative pressure therapy with a 
porous metal implant were to be further developed, a larger study consisting of larger groups 
would be necessary to establish statistical significance of any benefits of the therapy.  Another 
preliminary investigation would need to be done prior to a large animal study.   
 The inability to optimize the implant material for this application was another limitation 
of the study. We were unable to control certain characteristics of the material such as pore size 
and pore density because BIOFOAM™ is a proprietary material made by Wright Medical 
Technology, Inc.  The BIOFOAM™’s material characteristics were optimized by Wright, but the 
only information regarding BIOFOAM™ that was made available was characteristic data from 
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internal company reports referred to on marketing and sales brochures.  The original internal 
reports were not made available because it is against Wright Medical company policy.  The 
characteristics of the material given on the sales brochures are given in Section 1.3.1.  
Despite low numbers of animals, the inability to control the properties of BIOFOAM™, 
and the use of an animal model, this study established two useful models for the examination of 
negative pressure to induce bone and soft tissue ingrowth into porous metals.  The purpose of this 
study was to establish proof of concept for later studies and provide animal models for future 
studies upon which to improve.      
6.2 Future Directions  
6.2.1 Future Directions – Specific Aim #1 
 From a study execution standpoint, the femur location used in Specific Aim #1a 
presented several problems for the application of NPWT.  Negative pressure dressing changes, 
maintaining cleanliness of the underlying surgical site, and maintaining rigid fixation of the 
implant to the femur were all difficult.  Because of these concerns, two animals were added to the 
original Animal Care and Use Protocol (ACUP) to pilot an alternative location on the iliac crest 
that was believed to provide several advantages over the femur.  The iliac crest is further off the 
ground making dressing changes and inspection easier.  In addition, the surgical site is further 
from the anus and does not touch the ground when the animal is lying down, keeping feces and 
urine away from the incision thereby decreasing the likelihood of contamination and infection.  
The animal also cannot lay or fall on the implant, decreasing the likelihood of losing rigid implant 
fixation.  Lastly, the iliac crest provides an anchor point for many of the surrounding muscles and 
tendons, which inherently means less movement of the soft tissue over the implant as soft tissue 
tries to grow into the implant.  Movement of the surrounding soft tissue across the implants may 
have contributed to the formation of fluid filled bursas around some of the implants in Specific 
Aim #1.  Because of these benefits, it is recommended that the iliac crest be used for further soft 
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tissue, non-load bearing studies.  A more detailed description of the outcomes of the two animals 
that were piloted using the iliac crest can be found in Chapter 5.    
 Also deserving further investigation is the method in which negative pressure is applied 
to a sub-dermal porous implant.  The method used in Specific Aim #1 utilizing a transmittance 
sponge may be improved upon and deserves further investigation before further in vivo testing.   
6.2.2 Future Directions – Specific Aim #2 
 Looking long term, a permanent, non-degradable, metallic implant such as the 
BIOFOAM™ implant used, may not be ideal for repairing large, critical segmental defects.  A 
porous metal was used in this study to allow for focus of the effects of negative pressure therapy 
in such an application but a biodegradable material would be more desirable long term.  While 
there are no known materials currently available, the development of bioresorbable material to be 
used in an internal fixation device would be beneficial.  Such a material would need to provide 
the proper rigidity to initially stabilize a defect, the porosity necessary for the application of 
negative pressure to the surrounding tissue, and the ability to be degraded and absorbed by the 
body over time, allowing the eventual complete takeover of bone growth.    A standard implant 
size could be easily used in a surgically created bone defect such as an osteosarcoma osteotomy; 
however, such an implant is not easily adapted for the irregular segmental defects created by high 
impact trauma.  Unlike metals, if a material had the capability of being molded on site, it may 
also be able to better adapt to non-uniform defects like EWIs. 
A plating method of fixation was originally chosen for Specific Aim #2 so as not to 
interrupt the porous titanium implant, but the double plating technique may not provide rigid 
enough fixation for primary healing and bone growth to occur across the implant/bone interface.  
An FEA analysis of the two plate technique that was used would be beneficial to calculate the 
stresses and strains.  A better alternative to the two plate technique may be the use of an 
intramedullary (IM) nail.  This would disrupt the porous implant but maintaining even rigid 
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fixation may be more important for primary bone healing across the implant interface.  An IM 
nail could be combined with a biodegradable porous implant.   Mechanical testing and/or FEA 
analysis to verify the IM nailing technique is recommended before further in vivo testing. 
Lastly, similar to the future directions for Specific Aim #1, the optimization of the 
method of applying negative pressure therapy to a sub-dermal, porous metal implant in order to 
achieve longer duration of therapy deserves further investigation.  Several methods, including the 
two used in this study, were discussed in Section 5.4.  NPWT is currently mostly limited to 
surface applications and little is known about its potential in closed, sub-dermal wounds.  Finite 
element analysis, computer models or in vitro models offer potential methods through which to 
optimize the use of negative pressure in a sub-dermal application before further in vivo testing.  
Applying negative pressure therapy to bone for a longer duration may be necessary to have an 
effect on bone growth.  The durations that were achieved in this study (24-72 hours) were short 
relative to the time it takes bone to form (6 weeks).   
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Chapter 7 Conclusions 
 This study establishes the use of caprine models to evaluate soft tissue and bone ingrowth 
into large porous implants.  While the greater trochanter of the femur sufficed in Specific Aim #1 
for the purpose of this study, it is recommended based on two pilot animals, that future studies 
use the iliac crest as the implant location for future non-load bearing soft tissue studies.  The iliac 
crest provides a more sanitary and easily accessible location over the greater trochanter with less 
likelihood of the goat damaging fixation of the implant and less movement in the surrounding soft 
tissue.  
In all six animals of Specific Aim #1, gross examination showed improved tissue 
adhesion to the implant treated with NPWT when compared to the control despite the level of 
negative pressure of duration of study period.  While numbers are insufficient to establish 
statistical significance, this study provides preliminary evidence that negative pressure may 
induce soft tissue ingrowth into a large porous titanium implant that could be beneficial for future 
investigation.  
Specific Aim #2 established a unilateral model for the future study of segmental defects 
and methods to repair such injuries.  A benefit of negative pressure therapy on bone growth from 
the therapy durations used in this study was not able to be established; however, longer durations 
of therapy may have a greater impact on bone growth.  For future studies, it is recommended that 
all study terms be carried out to at least 12 weeks in order to see some bone remodeling occur.  In 
addition, mechanical strength of an intramedullary nail and validation of the best method of 
application of negative pressure therapy should be evaluated through either a computer model or 
in vitro model before future in vivo studies are carried out.        
This study establishes two in vivo caprine models that can be used to evaluate a device 
combining NPWT with a porous implant that could be used in repairing large injuries with 
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defects in soft tissue such as people suffering EWIs, bone cancer, or other traumatic injury and 
establishes two animal models for evaluation of such a device. 
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Appendix A:   Medication List 
Table 12. Medications used with usage and dosing information 
Drug Class of Drug Dose Route Duration of 
Treatment 
cephalaozine antibiotic  15 mg/kg SQ once preop 
xylazine anesthetic 0.03 mg/kg IM 
once for 
surgery, once 
each time for 
sedation 
ketamine general anesthetic 5 mg/kg IM 
once at 
induction 
ketamine general anesthetic 10 mg/kg IM 
weekly as 
needed for x-
ray 
diazepam 
benzodiazepine 
derivative 
0.4 mg/kg IV 
once at 
induction 
morphine narcotic 0.1 mg/kg Epidural 
once at 
induction 
flunixin nSAID coxib 1 mg/kg IV 
once at 
induction 
buprenorphrine narcotic/analgesic 0.005 mg/kg IM 
once 4 hrs 
postop and BID 
for 72 hours 
beuthanasia-D 
special (sodium 
pentobarbital) 
barbiturate 
90 mg/kg 
(0.22 mL/kg) 
IV once 
lidocane amide/anesthetic 1 mg/kg SQ once 
pancurium paralytic 0.06 mg/kg IV once 
isoflurane general anesthetic 1-2% Inhalation 
until 
disconnected 
oxytetracycline 
broad spectrum 
polyketide 
antibiotic/fluorochrome 
25 mg/kg IM 
week 4 and 
week 10 
calcein green fluorochrome 20 mg/kg SQ 
week 2 and 
week 8 
xylenol orange fluorochrome 90 mg/kg SQ week 6 
fentanyl analgesic 
50 mgc/hr/3 
days 
TD once, as needed 
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Appendix B:   Histology Embedding Protocol 
Table 13. Step by step embedding protocol in table format 
Solution Time Temperature 
Additional 
Treatment 
Neutral Buffered 
10% Formalin 
24 hours Room 
Vacuum 6 hours 
Agitate 18 hours 
Neutral Buffered 
10% Formalin 
24 hours Room 
Vacuum 6 hours 
Agitate 18 hours 
Neutral Buffered 
10% Formalin 
24 hours Room 
Vacuum 6 hours 
Agitate 18 hours 
100% Acetone 24 hours Room 
Vacuum 6 hours 
Agitate 18 hours 
100% Acetone 24 hours Room 
Vacuum 6 hours 
Agitate 18 hours 
50% Spurr Resin:       
50% Acetone 
24 hours Room 
Vacuum 6 hours 
 
75% Spurr Resin:       
25% Acetone 
24 hours Room 
Vacuum 6 hours 
 
100% Spurr Resin 24 hours Room 
Vacuum 6 hours 
 
100% Spurr Resin 24 hours Room Vacuum 24 hours 
Embed in 100% 
Spurr with Activator 
72 hours Room Vacuum 72 hours 
Move to refrigeration 11 days 4 
○
C - 
Move to incubator 
Until hard (~72 
hours) 
45 
○
C - 
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Appendix C:   Histology Sectioning and Grinding Protocol 
Table 14. Histology grinding protocol 
Paper Grit Final section thickness 
120 300 µm 
180 220 µm 
240 200 µm 
320 180 µm 
400 150 µm 
600 100 µm 
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Appendix D:   H&E Staining Protocol 
Table 15. H&E staining protocol 
Step Solution Medium Time 
1 Epoxy Resin Removal Kit 30 minutes 
2 100% Anhydrous Alcohol 3 minutes 
3 100% Anhydrous Alcohol 3 minutes 
4 80% Alcohol 2 minutes 
5 Tap water rinse 30 seconds 
6 Deionized water rinse 30 seconds 
7 Hematoxylin 1-5 minutes 
8 Tap water rinse 1 minute 
9 Define solution 30-90 seconds 
10 Tap water rinse 1 minute 
11 Blue Buffer solution 30-60 seconds 
12 Tap water rinse 30-60 seconds 
13 80% Alcohol 1 minute 
14 Alcoholic Eosin 30-90 seconds 
15 80% Alcohol 2 minutes 
16 100% Anhydrous Alcohol 3 minutes 
17 100% Anhydrous Alcohol 3 minutes 
18 Xylene 5 minutes 
19 Xylene 5 minutes 
20 Xylene 5 minutes 
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Appendix E:   Complete List of Surgical Supplies (not all shown in pictures)
Instruments 
 
 2 - needle holders 
 2 - pairs of dissecting scissors 
 2 - pairs of suture scissors 
 2 - baby Hohmann retractors 
 2 - army/navy retractors 
 1 - set of plate benders 
 2 - screwdrivers 
 2 - scalpal handles 
 6 - vascular clamps 
 1 - Rongeur 
 1 - 30 mL irrigation syringe 
 2 - small metal bowls 
 6 - towel clamps 
 2 - saw blades 
 3 - drill bits 
 1 - drill guide 
 1 - depth gage 
 2 - Verbruge clamps 
 1 - power drill 
 1 - power drill cord 
 1 - drill chuck with key 
 1 - Screw cutters 
 cerclage wire 
 1 - Cobb 
 1 - osteotome 
 1 - mallet 
 1 - Weitlaner Retractor 
 1 - small tissue forceps 
 1 - medium tissue forceps 
 Cutting guide 
 2 - stainless steel ¾”, 8-32 machine 
screws 
 2 - stainless steel ½”, 8-32 machine 
screws 
 2 - porous metal tibial implants 
(Wright Medical Technology, Inc.; 
Arlington, TN) 
 20 - 4 by 4 gauze sponges  
 2 - 30 by 30 impermeable drapes 
 
Purchased from Veterinary Orthopedic 
Implants, St. Augustine, FL 
 
 1 - tap 
 1 - tap guide 
 1 - tap handle 
 Bicortical screws 
o 10 - 18mm 3.5 mm dia. 
screws 
o 10 - 20 mm 3.5 mm dia. 
screws 
o 10 - 22 mm 3.5 mm dia. 
screws 
o 10 - 24 mm 3.5 mm dia. 
screws 
o 10 - 26 mm 3.5 mm dia. 
screws 
o 10 - 30 mm 3.5 mm dia. 
screws 
o 10 - 34 mm 3.5 mm dia. 
screws 
 2 - 10 mm 12-hole compression 
plates 
 2 - 10 mm 8-hole slotted plates 
 2 - 10 mm 12-hole compression 
plates 
 2 - 10 mm 8-hole slotted plates   
 
Other Consumables 
 
 Sterile gown 
 Ioban Drape 
 Impermeable Extremity Drape 
 3-0 Vicryl suture 
 2-0 Vicryl suture 
 1 mL Heparin (10,000 units/mL) 
 1 - syringe and needle for heparin 
 500 mL irrigation saline 
 V.A.C. dressing 
 V.A.C. Freedom® pump 
 channel drain 
 drain bulb 
 face masks 
 shoe booties 
 sterile surgical gloves 
 sterile towels 
 Veet® 
 No. 15 scalpel blades 
 Power unit for drill 
 Camera 
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Figures 24, 25, 26. Surgical Kit 
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Appendix F:   V.A.C. Freedom
®
 Alarm Troubleshooting Quick 
Reference guide 
Figure 27. V.A.C. Freedom
®
 Alarm Troubleshooting Quick Reference guide page 1. 
 
Figure 28. V.A.C. Freedom
®
 Alarm Troubleshooting Quick Reference guide page 2. 
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Appendix G:   Post surgery record forms  
Figure 29. Weight record form. 
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Figure 30. Medication record form. 
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Figure 31. Gait progress form 
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Figure 32. Temperature record form. 
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Figure 33. Anesthesia/surgery records form 
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Figure 34. Therapy record form. 
  
